Autoinflammatory and autoimmune conditions at the crossroad of COVID-19

Coronavirus disease 2019 (COVID-19) has been categorized as evolving in overlapping phases. First, there is a viral phase that may well be asymptomatic or mild in the majority, perhaps 80% of patients. The pathophysiological mechanisms resulting in minimal disease in this initial phase are not well...

Full description

Saved in:
Bibliographic Details
Published inJournal of autoimmunity Vol. 114; p. 102506
Main Authors Rodríguez, Yhojan, Novelli, Lucia, Rojas, Manuel, De Santis, Maria, Acosta-Ampudia, Yeny, Monsalve, Diana M., Ramírez-Santana, Carolina, Costanzo, Antonio, Ridgway, William M., Ansari, Aftab A., Gershwin, M. Eric, Selmi, Carlo, Anaya, Juan-Manuel
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.11.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Coronavirus disease 2019 (COVID-19) has been categorized as evolving in overlapping phases. First, there is a viral phase that may well be asymptomatic or mild in the majority, perhaps 80% of patients. The pathophysiological mechanisms resulting in minimal disease in this initial phase are not well known. In the remaining 20% of cases, the disease may become severe and/or critical. In most patients of this latter group, there is a phase characterized by the hyperresponsiveness of the immune system. A third phase corresponds to a state of hypercoagulability. Finally, in the fourth stage organ injury and failure occur. Appearance of autoinflammatory/autoimmune phenomena in patients with COVID-19 calls attention for the development of new strategies for the management of life-threatening conditions in critically ill patients. Antiphospholipid syndrome, autoimmune cytopenia, Guillain-Barré syndrome and Kawasaki disease have each been reported in patients with COVID-19. Here we present a scoping review of the relevant immunological findings in COVID-19 as well as the current reports about autoinflammatory/autoimmune conditions associated with the disease. These observations have crucial therapeutic implications since immunomodulatory drugs are at present the most likely best candidates for COVID-19 therapy. Clinicians should be aware of these conditions in patients with COVID-19, and these observations should be considered in the current development of vaccines. •Autoimmune and autoinflammatory conditions may be triggered by SARS-CoV-2.•Bystander activation and molecular mimicry could explain the appearance of these conditions.•In severe and critical patients, a cytokine storm syndrome (CSS) and a hypercoagulable state occur and may overlap.•CSS may promote the appearance of autoimmune and autoinflammatory-like conditions.•These observations should be considered in the current development of vaccines.
AbstractList Coronavirus disease 2019 (COVID-19) has been categorized as evolving in overlapping phases. First, there is a viral phase that may well be asymptomatic or mild in the majority, perhaps 80% of patients. The pathophysiological mechanisms resulting in minimal disease in this initial phase are not well known. In the remaining 20% of cases, the disease may become severe and/or critical. In most patients of this latter group, there is a phase characterized by the hyperresponsiveness of the immune system. A third phase corresponds to a state of hypercoagulability. Finally, in the fourth stage organ injury and failure occur. Appearance of autoinflammatory/autoimmune phenomena in patients with COVID-19 calls attention for the development of new strategies for the management of life-threatening conditions in critically ill patients. Antiphospholipid syndrome, autoimmune cytopenia, Guillain-Barré syndrome and Kawasaki disease have each been reported in patients with COVID-19. Here we present a scoping review of the relevant immunological findings in COVID-19 as well as the current reports about autoinflammatory/autoimmune conditions associated with the disease. These observations have crucial therapeutic implications since immunomodulatory drugs are at present the most likely best candidates for COVID-19 therapy. Clinicians should be aware of these conditions in patients with COVID-19, and these observations should be considered in the current development of vaccines.
Coronavirus disease 2019 (COVID-19) has been categorized as evolving in overlapping phases. First, there is a viral phase that may well be asymptomatic or mild in the majority, perhaps 80% of patients. The pathophysiological mechanisms resulting in minimal disease in this initial phase are not well known. In the remaining 20% of cases, the disease may become severe and/or critical. In most patients of this latter group, there is a phase characterized by the hyperresponsiveness of the immune system. A third phase corresponds to a state of hypercoagulability. Finally, in the fourth stage organ injury and failure occur. Appearance of autoinflammatory/autoimmune phenomena in patients with COVID-19 calls attention for the development of new strategies for the management of life-threatening conditions in critically ill patients. Antiphospholipid syndrome, autoimmune cytopenia, Guillain-Barré syndrome and Kawasaki disease have each been reported in patients with COVID-19. Here we present a scoping review of the relevant immunological findings in COVID-19 as well as the current reports about autoinflammatory/autoimmune conditions associated with the disease. These observations have crucial therapeutic implications since immunomodulatory drugs are at present the most likely best candidates for COVID-19 therapy. Clinicians should be aware of these conditions in patients with COVID-19, and these observations should be considered in the current development of vaccines. • Autoimmune and autoinflammatory conditions may be triggered by SARS-CoV-2. • Bystander activation and molecular mimicry could explain the appearance of these conditions. • In severe and critical patients, a cytokine storm syndrome (CSS) and a hypercoagulable state occur and may overlap. • CSS may promote the appearance of autoimmune and autoinflammatory-like conditions. • These observations should be considered in the current development of vaccines.
Coronavirus disease 2019 (COVID-19) has been categorized as evolving in overlapping phases. First, there is a viral phase that may well be asymptomatic or mild in the majority, perhaps 80% of patients. The pathophysiological mechanisms resulting in minimal disease in this initial phase are not well known. In the remaining 20% of cases, the disease may become severe and/or critical. In most patients of this latter group, there is a phase characterized by the hyperresponsiveness of the immune system. A third phase corresponds to a state of hypercoagulability. Finally, in the fourth stage organ injury and failure occur. Appearance of autoinflammatory/autoimmune phenomena in patients with COVID-19 calls attention for the development of new strategies for the management of life-threatening conditions in critically ill patients. Antiphospholipid syndrome, autoimmune cytopenia, Guillain-Barré syndrome and Kawasaki disease have each been reported in patients with COVID-19. Here we present a scoping review of the relevant immunological findings in COVID-19 as well as the current reports about autoinflammatory/autoimmune conditions associated with the disease. These observations have crucial therapeutic implications since immunomodulatory drugs are at present the most likely best candidates for COVID-19 therapy. Clinicians should be aware of these conditions in patients with COVID-19, and these observations should be considered in the current development of vaccines. •Autoimmune and autoinflammatory conditions may be triggered by SARS-CoV-2.•Bystander activation and molecular mimicry could explain the appearance of these conditions.•In severe and critical patients, a cytokine storm syndrome (CSS) and a hypercoagulable state occur and may overlap.•CSS may promote the appearance of autoimmune and autoinflammatory-like conditions.•These observations should be considered in the current development of vaccines.
Coronavirus disease 2019 (COVID-19) has been categorized as evolving in overlapping phases. First, there is a viral phase that may well be asymptomatic or mild in the majority, perhaps 80% of patients. The pathophysiological mechanisms resulting in minimal disease in this initial phase are not well known. In the remaining 20% of cases, the disease may become severe and/or critical. In most patients of this latter group, there is a phase characterized by the hyperresponsiveness of the immune system. A third phase corresponds to a state of hypercoagulability. Finally, in the fourth stage organ injury and failure occur. Appearance of autoinflammatory/autoimmune phenomena in patients with COVID-19 calls attention for the development of new strategies for the management of life-threatening conditions in critically ill patients. Antiphospholipid syndrome, autoimmune cytopenia, Guillain-Barré syndrome and Kawasaki disease have each been reported in patients with COVID-19. Here we present a scoping review of the relevant immunological findings in COVID-19 as well as the current reports about autoinflammatory/autoimmune conditions associated with the disease. These observations have crucial therapeutic implications since immunomodulatory drugs are at present the most likely best candidates for COVID-19 therapy. Clinicians should be aware of these conditions in patients with COVID-19, and these observations should be considered in the current development of vaccines.Coronavirus disease 2019 (COVID-19) has been categorized as evolving in overlapping phases. First, there is a viral phase that may well be asymptomatic or mild in the majority, perhaps 80% of patients. The pathophysiological mechanisms resulting in minimal disease in this initial phase are not well known. In the remaining 20% of cases, the disease may become severe and/or critical. In most patients of this latter group, there is a phase characterized by the hyperresponsiveness of the immune system. A third phase corresponds to a state of hypercoagulability. Finally, in the fourth stage organ injury and failure occur. Appearance of autoinflammatory/autoimmune phenomena in patients with COVID-19 calls attention for the development of new strategies for the management of life-threatening conditions in critically ill patients. Antiphospholipid syndrome, autoimmune cytopenia, Guillain-Barré syndrome and Kawasaki disease have each been reported in patients with COVID-19. Here we present a scoping review of the relevant immunological findings in COVID-19 as well as the current reports about autoinflammatory/autoimmune conditions associated with the disease. These observations have crucial therapeutic implications since immunomodulatory drugs are at present the most likely best candidates for COVID-19 therapy. Clinicians should be aware of these conditions in patients with COVID-19, and these observations should be considered in the current development of vaccines.
ArticleNumber 102506
Author Ridgway, William M.
Acosta-Ampudia, Yeny
Gershwin, M. Eric
Novelli, Lucia
Anaya, Juan-Manuel
Ansari, Aftab A.
Ramírez-Santana, Carolina
Costanzo, Antonio
De Santis, Maria
Selmi, Carlo
Rojas, Manuel
Monsalve, Diana M.
Rodríguez, Yhojan
Author_xml – sequence: 1
  givenname: Yhojan
  surname: Rodríguez
  fullname: Rodríguez, Yhojan
  organization: Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia
– sequence: 2
  givenname: Lucia
  surname: Novelli
  fullname: Novelli, Lucia
  organization: Rheumatology and Clinical Immunology, Humanitas Clinical and Research Center (IRCCS), Rozzano, Milan, Italy
– sequence: 3
  givenname: Manuel
  surname: Rojas
  fullname: Rojas, Manuel
  organization: Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia
– sequence: 4
  givenname: Maria
  surname: De Santis
  fullname: De Santis, Maria
  organization: Rheumatology and Clinical Immunology, Humanitas Clinical and Research Center (IRCCS), Rozzano, Milan, Italy
– sequence: 5
  givenname: Yeny
  surname: Acosta-Ampudia
  fullname: Acosta-Ampudia, Yeny
  organization: Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia
– sequence: 6
  givenname: Diana M.
  surname: Monsalve
  fullname: Monsalve, Diana M.
  organization: Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia
– sequence: 7
  givenname: Carolina
  surname: Ramírez-Santana
  fullname: Ramírez-Santana, Carolina
  organization: Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia
– sequence: 8
  givenname: Antonio
  surname: Costanzo
  fullname: Costanzo, Antonio
  organization: Dermatology, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy
– sequence: 9
  givenname: William M.
  surname: Ridgway
  fullname: Ridgway, William M.
  organization: Division of Rheumatology, Allergy, and Clinical Immunology, University of California, Davis, CA, USA
– sequence: 10
  givenname: Aftab A.
  surname: Ansari
  fullname: Ansari, Aftab A.
  organization: Division of Rheumatology, Allergy, and Clinical Immunology, University of California, Davis, CA, USA
– sequence: 11
  givenname: M. Eric
  surname: Gershwin
  fullname: Gershwin, M. Eric
  email: megershwin@ucdavis.edu
  organization: Division of Rheumatology, Allergy, and Clinical Immunology, University of California, Davis, CA, USA
– sequence: 12
  givenname: Carlo
  surname: Selmi
  fullname: Selmi, Carlo
  email: carlo.selmi@hunimed.eu
  organization: Rheumatology and Clinical Immunology, Humanitas Clinical and Research Center (IRCCS), Rozzano, Milan, Italy
– sequence: 13
  givenname: Juan-Manuel
  surname: Anaya
  fullname: Anaya, Juan-Manuel
  email: juan.anaya@urosario.edu.co
  organization: Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32563547$$D View this record in MEDLINE/PubMed
BookMark eNqFkU9L7DAUxYMoOv75Ai6kSzedl6RJ2ooIw-hTQXCjbkOapJqxTTRJhfn2ptQnTxe6Ctyc372Hc3bBpnVWA3CI4BxBxP6s5isxxDmGeBxgCtkGmCFY07xGtNwEM1jVLK8IQjtgN4QVhAhRSrfBToEpKygpZ-ByMURnbNuJvhfR-XUmrMrEOOz7wepMOqtMNM6GTMQsPqWJdyF4J1Tm2mx5-3B9nqN6H2y1ogv64OPdA_d_L-6WV_nN7eX1cnGTS1rimLekQTIZLRmiVUMbSERBGGZVWQmJkZItrHRB6oYgWGBVkYbiRilZM1JLqVWxB86mvS9D02sltY1edPzFm174NXfC8K8_1jzxR_fGS1yzArO04PhjgXevgw6R9yZI3XXCajcEjklyVjBSjtKj_299HvmXXhLgSTBFottPCYJ8rIiv-FgRHyviU0UJqr5B0kQxJpz8mu5n9HRCdUr4zWjPgzTaplyM1zJy5czP-Mk3XHbGGim6Z73-DX4H2r2_mA
CitedBy_id crossref_primary_10_5662_wjm_v12_i4_200
crossref_primary_10_1016_j_jaut_2022_102898
crossref_primary_10_3390_cells10102545
crossref_primary_10_3389_fimmu_2021_686699
crossref_primary_10_1002_jmv_28067
crossref_primary_10_1007_s00256_021_03734_7
crossref_primary_10_1111_1744_9987_14004
crossref_primary_10_1007_s11030_021_10244_0
crossref_primary_10_3389_fimmu_2023_1183570
crossref_primary_10_4254_wjh_v13_i10_1367
crossref_primary_10_3390_jcm12247587
crossref_primary_10_3390_pathogens10030380
crossref_primary_10_1016_j_autrev_2021_102865
crossref_primary_10_1016_j_autrev_2021_102985
crossref_primary_10_3389_fimmu_2021_788368
crossref_primary_10_1007_s42399_020_00527_2
crossref_primary_10_3390_ijerph20054207
crossref_primary_10_1007_s00296_022_05149_6
crossref_primary_10_15448_1980_6108_2022_1_42436
crossref_primary_10_1002_ppul_25612
crossref_primary_10_1016_j_jaut_2021_102598
crossref_primary_10_1016_j_jaut_2020_102511
crossref_primary_10_1038_s41565_020_00810_2
crossref_primary_10_1515_revneuro_2023_0024
crossref_primary_10_1016_j_eucr_2022_102017
crossref_primary_10_1016_j_actatropica_2021_106013
crossref_primary_10_7759_cureus_19616
crossref_primary_10_4103_jfmpc_jfmpc_2246_22
crossref_primary_10_1080_00365513_2022_2079095
crossref_primary_10_2174_1871526522666220321153712
crossref_primary_10_7759_cureus_27583
crossref_primary_10_1016_j_transci_2022_103625
crossref_primary_10_3390_life11030182
crossref_primary_10_1016_j_jtauto_2024_100237
crossref_primary_10_1007_s12185_023_03589_9
crossref_primary_10_2174_2666145415666221004111511
crossref_primary_10_1016_j_jtauto_2021_100091
crossref_primary_10_1007_s10620_023_07967_5
crossref_primary_10_33920_MED_12_2102_07
crossref_primary_10_1080_01676830_2021_1962366
crossref_primary_10_1016_j_jtauto_2020_100069
crossref_primary_10_1111_1346_8138_16590
crossref_primary_10_1055_s_0042_1759778
crossref_primary_10_1016_j_transci_2021_103339
crossref_primary_10_3390_ijms232113656
crossref_primary_10_1007_s13139_021_00730_6
crossref_primary_10_3390_v15020400
crossref_primary_10_3892_mmr_2021_12498
crossref_primary_10_1093_ehjcr_ytab143
crossref_primary_10_36233_0507_4088_130
crossref_primary_10_1177_1535370220986785
crossref_primary_10_3389_fcimb_2024_1410282
crossref_primary_10_1111_liv_15044
crossref_primary_10_31146_1682_8658_ecg_206_10_163_168
crossref_primary_10_1002_ccr3_5237
crossref_primary_10_3899_jrheum_210226
crossref_primary_10_1016_j_clim_2021_108896
crossref_primary_10_1016_j_nrleng_2020_07_011
crossref_primary_10_1016_j_transci_2023_103729
crossref_primary_10_1007_s00705_023_05773_y
crossref_primary_10_1111_ijd_15239
crossref_primary_10_1016_j_jaut_2022_102846
crossref_primary_10_21518_2079_701X_2020_17_66_73
crossref_primary_10_3390_ijms23031716
crossref_primary_10_1002_jmv_26921
crossref_primary_10_1080_13813455_2022_2080228
crossref_primary_10_1016_j_clim_2023_109882
crossref_primary_10_1177_09612033221098571
crossref_primary_10_3389_fimmu_2021_645013
crossref_primary_10_1007_s40265_020_01367_z
crossref_primary_10_52547_johe_10_1_12
crossref_primary_10_2957_kanzo_65_58
crossref_primary_10_31260_RepertMedCir_01217372_1402
crossref_primary_10_5021_ad_24_001
crossref_primary_10_24835_1607_0763_1232
crossref_primary_10_1590_1806_9282_20210602
crossref_primary_10_22625_2072_6732_2022_14_4_26_37
crossref_primary_10_1136_annrheumdis_2021_220044
crossref_primary_10_1007_s00117_021_00907_2
crossref_primary_10_1016_j_ajg_2022_07_001
crossref_primary_10_3389_fpubh_2024_1371110
crossref_primary_10_1097_ACI_0000000000000888
crossref_primary_10_1016_j_jtauto_2025_100281
crossref_primary_10_1016_j_nano_2022_102604
crossref_primary_10_1051_mbcb_2021003
crossref_primary_10_3389_fendo_2021_805647
crossref_primary_10_3389_fphar_2022_973246
crossref_primary_10_4236_wjns_2021_112015
crossref_primary_10_1016_j_autneu_2022_103071
crossref_primary_10_23868_202012013
crossref_primary_10_3390_jcm12093190
crossref_primary_10_1016_j_molimm_2021_06_021
crossref_primary_10_1111_cts_13297
crossref_primary_10_1177_03000605241233450
crossref_primary_10_1186_s12985_023_01989_1
crossref_primary_10_4103_injr_injr_114_21
crossref_primary_10_1016_j_jaut_2021_102687
crossref_primary_10_1007_s12026_023_09371_7
crossref_primary_10_3390_vaccines9080815
crossref_primary_10_1093_infdis_jiaa485
crossref_primary_10_3389_fimmu_2025_1510770
crossref_primary_10_1093_infdis_jiab330
crossref_primary_10_1111_exd_14407
crossref_primary_10_5339_qmj_2021_65
crossref_primary_10_1186_s12879_022_07610_0
crossref_primary_10_1016_j_nrl_2020_07_013
crossref_primary_10_3889_oamjms_2021_6766
crossref_primary_10_1016_j_biopha_2020_110698
crossref_primary_10_1186_s12974_022_02454_6
crossref_primary_10_3389_fmolb_2020_557377
crossref_primary_10_1177_11206721221123780
crossref_primary_10_1007_s12020_021_02881_0
crossref_primary_10_3389_fmolb_2022_804109
crossref_primary_10_1016_j_mehy_2020_110345
crossref_primary_10_3390_ijms232314688
crossref_primary_10_1016_j_intimp_2022_109061
crossref_primary_10_3389_fmed_2021_754667
crossref_primary_10_3390_microorganisms10010153
crossref_primary_10_1093_bib_bbac056
crossref_primary_10_3389_fnhum_2021_656313
crossref_primary_10_3390_genes13040676
crossref_primary_10_2478_rir_2021_0004
crossref_primary_10_1038_s41467_021_25102_8
crossref_primary_10_1016_j_etap_2020_103520
crossref_primary_10_3390_antib11040068
crossref_primary_10_1016_j_aace_2023_04_006
crossref_primary_10_1016_j_cellsig_2021_110121
crossref_primary_10_7883_yoken_JJID_2021_281
crossref_primary_10_1007_s40265_020_01421_w
crossref_primary_10_1016_j_jtauto_2021_100129
crossref_primary_10_1111_dth_14405
crossref_primary_10_1016_j_htct_2021_04_005
crossref_primary_10_3390_jcm12020601
crossref_primary_10_1016_j_jaut_2020_102592
crossref_primary_10_1159_000525562
crossref_primary_10_1007_s40744_022_00508_y
crossref_primary_10_1016_j_jtauto_2021_100137
crossref_primary_10_1007_s10787_022_01047_2
crossref_primary_10_1136_bcr_2021_247022
crossref_primary_10_1055_s_0042_1758118
crossref_primary_10_3389_fimmu_2022_859550
crossref_primary_10_3390_genes12020154
crossref_primary_10_3389_fmmed_2022_1035290
crossref_primary_10_3390_jcm10020191
crossref_primary_10_37871_jbres1297
crossref_primary_10_3390_vaccines9111346
crossref_primary_10_1080_15569527_2021_1919138
crossref_primary_10_1021_acsomega_2c04589
crossref_primary_10_17816_brmma72051
crossref_primary_10_1080_1744666X_2021_1905526
crossref_primary_10_3390_jcm9124021
crossref_primary_10_1183_16000617_0197_2022
crossref_primary_10_1016_j_jaut_2020_102580
crossref_primary_10_4103_injr_injr_76_22
crossref_primary_10_1155_2022_2934171
crossref_primary_10_1016_j_jaut_2021_102616
crossref_primary_10_1016_j_jiph_2022_01_007
crossref_primary_10_7759_cureus_29076
crossref_primary_10_3389_fimmu_2021_705772
crossref_primary_10_3390_life13061252
crossref_primary_10_1093_milmed_usad446
crossref_primary_10_1016_j_ekir_2023_03_016
crossref_primary_10_1016_j_isci_2021_103115
crossref_primary_10_23736_S1825_859X_21_00104_3
crossref_primary_10_3389_fimmu_2021_720363
crossref_primary_10_1016_j_cca_2023_117742
crossref_primary_10_1080_1744666X_2022_2085561
crossref_primary_10_1542_pir_2020_002782
crossref_primary_10_35627_2219_5238_2021_335_2_70_74
crossref_primary_10_1002_jmv_27175
crossref_primary_10_3389_fimmu_2021_732913
crossref_primary_10_1007_s10067_022_06106_1
crossref_primary_10_1080_08923973_2021_1988102
crossref_primary_10_1007_s00251_021_01250_5
crossref_primary_10_1016_j_autrev_2021_102792
crossref_primary_10_1136_bcr_2021_243880
crossref_primary_10_1111_bjh_17079
crossref_primary_10_1093_jnen_nlad005
crossref_primary_10_3350_cmh_2022_0233
crossref_primary_10_1007_s00508_021_01867_2
crossref_primary_10_7759_cureus_41498
crossref_primary_10_1016_j_mehy_2021_110677
crossref_primary_10_1093_jleuko_qiae002
crossref_primary_10_1016_j_neurol_2022_11_009
crossref_primary_10_1016_j_lfs_2023_121531
crossref_primary_10_3390_v15102045
crossref_primary_10_3389_fimmu_2023_1308477
crossref_primary_10_1016_j_lfs_2022_121018
crossref_primary_10_1016_j_gaceta_2022_03_002
crossref_primary_10_18705_2782_3806_2023_3_2_46_56
crossref_primary_10_1080_08820139_2021_1876086
crossref_primary_10_1111_ijcp_14886
crossref_primary_10_3390_v13050932
crossref_primary_10_1016_j_compbiomed_2023_106855
crossref_primary_10_1172_JCI154886
crossref_primary_10_3389_fimmu_2022_985433
crossref_primary_10_3390_biomedicines9081003
crossref_primary_10_46497_ArchRheumatol_2024_10330
crossref_primary_10_1080_01635581_2021_1957128
crossref_primary_10_1038_s41598_022_15467_1
crossref_primary_10_14309_crj_0000000000000652
crossref_primary_10_3389_fneur_2021_657004
crossref_primary_10_1155_2022_1622160
crossref_primary_10_1101_cshperspect_a041157
crossref_primary_10_3390_vaccines10122073
crossref_primary_10_3389_fimmu_2021_719023
crossref_primary_10_47360_1995_4484_2021_5_30
crossref_primary_10_1016_j_mehy_2021_110538
crossref_primary_10_3390_medicina57030253
crossref_primary_10_3389_fimmu_2022_1052850
Cites_doi 10.1007/s10072-020-04449-8
10.3201/eid1310.070576
10.1212/NXI.0000000000000741
10.1038/cmi.2017.142
10.2174/1389202916666141223220551
10.1016/S0140-6736(20)30868-0
10.5812/jjm.11014
10.1016/j.chom.2020.04.009
10.7554/eLife.57555
10.1016/j.autrev.2020.102554
10.1007/s00134-020-06062-x
10.1016/j.jinf.2020.04.017
10.1111/jns.12382
10.1016/j.chom.2020.04.017
10.1007/s12250-020-00207-4
10.1126/science.1140485
10.1016/j.cell.2020.02.052
10.4049/jimmunol.1101284
10.1172/JCI140200
10.1371/journal.pmed.0030297
10.1007/s10067-018-4209-9
10.1111/tan.13941
10.1186/s40425-018-0343-9
10.1016/j.berh.2012.07.002
10.3390/v11080762
10.1016/j.ijid.2020.03.013
10.1016/j.jaut.2019.06.012
10.1002/art.40071
10.1186/ar4193
10.4049/jimmunol.176.12.7278
10.1016/j.immuni.2020.06.001
10.1016/j.ebiom.2020.102763
10.1172/JCI200112173
10.1016/j.genm.2011.10.003
10.1016/j.cgh.2020.05.047
10.1038/s41423-018-0004-4
10.1016/S0140-6736(20)30183-5
10.3389/fpubh.2020.00152
10.55563/clinexprheumatol/xcdary
10.1097/01.md.0000157397.30055.c9
10.1056/NEJMc2007575
10.1038/s41577-020-0311-8
10.1016/j.clim.2020.108426
10.3389/fimmu.2019.00119
10.1016/S0140-6736(20)30980-6
10.1016/S2352-3026(20)30175-7
10.1161/CIRCULATIONAHA.120.048360
10.1073/pnas.2005615117
10.1089/jir.2011.0047
10.1371/journal.pone.0215665
10.1016/j.autrev.2014.01.058
10.1111/j.1365-2249.2005.02821.x
10.1056/NEJMoa2001017
10.1186/ar1208
10.3389/fimmu.2019.01532
10.1002/jmv.25866
10.1093/infdis/jiq136
10.1155/2013/981232
10.1136/ard.47.9.764
10.1038/s41423-020-0402-2
10.1016/j.autrev.2020.102556
10.2217/imt-2016-0020
10.1016/S0140-6736(20)31094-1
10.1111/j.1749-6632.1997.tb52078.x
10.1002/eji.200939444
10.1016/j.jaut.2011.10.003
10.1542/hpeds.2020-0123
10.1016/j.clim.2020.108480
10.1177/0961203319838063
10.1136/bmj.m2123
10.1159/000312628
10.1093/infdis/jiv380
10.1038/s41392-020-0148-4
10.1016/j.bbi.2020.04.074
10.1007/s12016-019-08747-8
10.1016/j.autrev.2012.07.018
10.1038/nri3190
10.1111/j.1600-065X.2009.00766.x
10.1038/s41591-020-0819-2
10.1016/j.jocn.2020.05.016
10.1001/jama.2020.8259
10.1016/j.clinph.2020.05.003
10.1007/s00134-020-05991-x
10.1128/JVI.06791-11
10.1136/annrheumdis-2020-217549
10.1007/s10067-010-1581-5
10.1212/WNL.0000000000009619
10.1016/j.jaut.2020.102442
10.1093/cid/ciaa248
10.1038/s41586-020-2012-7
10.1093/cid/ciaa638
10.1212/WNL.0000000000009921
10.4049/jimmunol.180.11.7112
10.1126/sciimmunol.abc3582
10.1182/blood-2006-10-043463
10.1136/annrheumdis-2020-217442
10.3389/fimmu.2020.00827
10.1038/s41591-020-0868-6
10.1016/j.berh.2014.03.002
10.2337/db07-1023
10.1038/s41564-020-0688-y
10.1016/S0140-6736(13)61048-X
10.1136/annrheumdis-2020-217362
10.1172/JCI138745
10.1186/s40249-020-00662-x
10.1016/j.cell.2020.04.026
10.1016/S1074-7613(02)00338-2
10.1056/NEJMc2010472
10.1056/NEJMc2011400
10.1111/imr.12109
10.1002/jmv.25715
10.1016/j.jaut.2018.10.012
10.1002/jmv.25801
10.1172/jci.insight.123158
10.1111/bjd.18203
10.1016/S2213-2600(20)30076-X
10.1007/s00281-017-0629-x
10.1016/S0140-6736(20)31103-X
10.4014/jmb.2003.03011
10.1172/JCI138554
10.1038/s41591-020-0897-1
10.1056/NEJMc2009191
10.1164/rccm.202003-0543OC
10.1007/s12026-013-8448-1
10.1016/S0140-6736(20)30628-0
10.1111/bjd.19163
10.3109/08916930903405891
10.1016/j.meegid.2020.104389
10.1093/infdis/jiaa150
10.1111/bjh.16850
10.1002/jmv.26138
10.1016/j.autrev.2020.102572
10.1016/j.ijid.2020.03.003
10.1016/j.autrev.2018.04.002
10.1016/j.semarthrit.2020.05.010
10.1038/nm.2028
10.1073/pnas.1614472114
10.1136/annrheumdis-2020-217562
10.1182/blood-2005-02-0456
10.1016/j.xcrm.2020.100040
10.1111/bjh.16794
10.1021/acschemneuro.0c00122
10.1177/1759720X13502919
10.1056/NEJMc2013656
10.1016/j.antiviral.2020.104762
10.1016/j.autrev.2020.102575
10.1111/imm.12929
10.1186/s12974-018-1246-x
10.1371/journal.pone.0045842
10.1111/bjh.16786
10.1016/j.jmii.2020.03.005
10.1016/j.imlet.2004.10.022
10.1016/j.idcr.2020.e00771
10.1136/annrheumdis-2013-203883
10.1007/s10067-015-2868-3
ContentType Journal Article
Copyright 2020 Elsevier Ltd
Copyright © 2020 Elsevier Ltd. All rights reserved.
2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd
Copyright_xml – notice: 2020 Elsevier Ltd
– notice: Copyright © 2020 Elsevier Ltd. All rights reserved.
– notice: 2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1016/j.jaut.2020.102506
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE


MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1095-9157
EndPage 102506
ExternalDocumentID PMC7296326
32563547
10_1016_j_jaut_2020_102506
S0896841120301281
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29J
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
9JM
AAAJQ
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFRF
ABJNI
ABMAC
ABMZM
ABOCM
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADFGL
ADMUD
ADNMO
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGEKW
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
CJTIS
COF
CS3
DM4
DU5
EBS
EFBJH
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDU
HMG
HMK
HMO
HVGLF
HZ~
IHE
J1W
KOM
LG5
LUGTX
LZ5
M29
M41
MO0
N9A
O-L
O9-
O9~
OAUVE
OK0
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SES
SEW
SIN
SPCBC
SSH
SSI
SSZ
T5K
WUQ
XPP
Z5R
ZGI
ZMT
ZU3
~G-
AACTN
AAIAV
ABLVK
ABYKQ
AFCTW
AFKWA
AJBFU
AJOXV
AMFUW
EFLBG
LCYCR
RIG
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c572t-f4b1c50676158b5b04a34626878ac21dcf08e349b41032d84b52bddc9649cced3
IEDL.DBID .~1
ISSN 0896-8411
1095-9157
IngestDate Thu Aug 21 14:07:24 EDT 2025
Tue Aug 05 10:26:25 EDT 2025
Thu Apr 03 07:06:30 EDT 2025
Thu Apr 24 23:00:55 EDT 2025
Tue Jul 01 03:24:10 EDT 2025
Fri Feb 23 02:47:55 EST 2024
Tue Aug 26 18:13:50 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords COVID-19
Autoimmunity
SARS-CoV-2
Kawasaki disease
Cytokine storm syndrome
Vaccines
Cytopenia
Guillain-Barré syndrome
Antiphospholipid syndrome
Language English
License Copyright © 2020 Elsevier Ltd. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c572t-f4b1c50676158b5b04a34626878ac21dcf08e349b41032d84b52bddc9649cced3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Authors contributed equally to this manuscript.
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC7296326
PMID 32563547
PQID 2415836476
PQPubID 23479
PageCount 1
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7296326
proquest_miscellaneous_2415836476
pubmed_primary_32563547
crossref_primary_10_1016_j_jaut_2020_102506
crossref_citationtrail_10_1016_j_jaut_2020_102506
elsevier_sciencedirect_doi_10_1016_j_jaut_2020_102506
elsevier_clinicalkey_doi_10_1016_j_jaut_2020_102506
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-11-01
PublicationDateYYYYMMDD 2020-11-01
PublicationDate_xml – month: 11
  year: 2020
  text: 2020-11-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Journal of autoimmunity
PublicationTitleAlternate J Autoimmun
PublicationYear 2020
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Gutiérrez-Ortiz, Méndez, Rodrigo-Rey, San Pedro-Murillo, Bermejo-Guerrero, Gordo-Mañas, de Aragón-Gómez, Benito-León (bib26) 2020
Kanduc, Shoenfeld (bib176) 2020; 215
Behrens, Koretzky (bib125) 2017; 69
Bin Dhuban, Bartolucci, D'Hennezel, Piccirillo (bib146) 2019; 10
Moutsopoulos (bib135) 2020
Wouters, van der Veen, van de Putte, de Rooij (bib18) 1988; 47
Braun, Loyal, Frentsch, Wendisch, Georg, Kurth, Hippenstiel, Dingeldey, Kruse, Fauchere, Baysal, Mangold, Henze, Lauster, Mall, Beyer, Roehmel, Schmitz, Miltenyi, Mueller, Witzenrath, Suttorp, Kern, Reimer, Wenschuh, Drosten, Corman, Giesecke-Thiel, Sander, Thiel (bib97) 2020
Quintero, Amador-Patarroyo, Montoya-Ortiz, Rojas-Villarraga, Anaya (bib160) 2012; 38
Castiblanco, Anaya (bib194) 2015; 16
Zhou, Ren, Zhang, Zhong, Xiao, Jia, Guo, Yang, Wang, Jiang, Yang, Zhang, Li, Chen, Xu, Chen, Gao, Yang, Dong, Liu, Zhang, Wang, He, Jin, Li, Wang (bib73) 2020; 27
Emmi, Bettiol, Mattioli, Silvestri, Di Scala, Urban, Vaglio, Prisco (bib139) 2020; 19
Wu, Yang (bib124) 2020; 53
Cacoub, Terrier, Saadoun (bib13) 2014; 73
Zhang, Xiao, Zhang, Xia, Cao, Jiang, Chen, Ding, Zhao, Zhang, Wang, Zhao, Sun, Tian, Wu, Wu, Ma, Chen, Zhang, Xie, Yan, Zhou, Liu, Wang, Du, Qin, Gao, Qin, Xu, Zhang, Li, Zhang, Zhao, Li, Zhang (bib43) 2020; 382
Behrens (bib128) 2019
Scheidl, Canseco, Hadji‐Naumov, Bereznai (bib23) 2020
Meng-Yuan, Lin, Yue, Xiao-Sheng (bib63) 2020; 9
Rawlings, Schwartz, Jackson, Meyer-Bahlburg (bib56) 2012; 12
Rowley, Baker, Shulman, Rand, Tretiakova, Perlman, Garcia, Tajuddin, Fox, Huang, Ralphe, Takahashi, Flatow, Lin, Kalelkar, Soriano, Orenstein (bib185) 2011; 203
Ahn, Shin, Kim, Lee, Kim, Myoung, Kim, Kim (bib48) 2020; 30
Shamsizadeh, Ziaei Kajbaf, Razavi, Cheraghian (bib181) 2014; 7
Riphagen, Gomez, Gonzalez-Martinez, Wilkinson, Theocharis (bib38) 2020; 395
Ahmed, Khakwani, Venkatadasari, Horgan, Giles, Jobanputra, Lokare, Ewing, Paneesha, Murthy (bib33) 2020
Qin, Zhou, Hu, Zhang, Yang, Tao, Xie, Ma, Shang, Wang, Tian (bib71) 2020
Yang, Shen, Li, Yuan, Yang, Wang, Li, Li, Xing, Peng, Wei, Cao, Zheng, Wu, Zou, Li, Xu, Wang, Zhang, Zhang, Liu, Liu (bib82) 2020
Belhadjer, Méot, Bajolle, Khraiche, Legendre, Abakka, Auriau, Grimaud, Oualha, Beghetti, Wacker, Ovaert, Hascoet, Selegny, Malekzadeh-Milani, Maltret, Bosser, Giroux, Bonnemains, Bordet, Di Filippo, Mauran, Falcon-Eicher, Thambo, Lefort, Moceri, Houyel, Renolleau, Bonnet (bib41) 2020
Ramos-Casals, Loustaud-Ratti, De Vita, Zeher, Bosch, Toussirot, Medina, Rosas, Anaya, Font (bib14) 2005; 84
Rigamonti, Cittone, De Benedittis, Rizzi, Casciaro, Bellan, Sainaghi, Pirisi (bib140) 2020
Gorse, Donovan, Patel (bib171) 2020; 92
Sethuraman, Jeremiah, Ryo (bib5) 2020; 323
Toubiana, Poirault, Corsia, Bajolle, Fourgeaud, Angoulvant, Debray, Basmaci, Salvador, Biscardi, Frange, Chalumeau, Casanova, Cohen, Allali (bib42) 2020; 369
Harzallah, Debliquis, Drénou (bib44) 2020
Liu, Wei, Lin, Fang, Wang, Kwok, Tang, Nishiura, Peng, Tan, Wu, Cheung, Chan, Alvarez, Qin, Lackner, Perlman, Yuen, Chen (bib119) 2019; 4
(bib172) 2020
Bullard, Dust, Funk, Strong, Alexander, Garnett, Boodman, Bello, Hedley, Schiffman, Doan, Bastien, Li, Van Caeseele, Poliquin (bib174) 2020
Tanaka, Narazaki, Kishimoto (bib129) 2016; 8
Zhang, Qin, Deng, Ma, Guo, Guo, Hou, Wang, Zou, Sun, Ma, Hou (bib163) 2018; 15
Zhou, Yang, Wang, Hu, Zhang, Zhang, Si, Zhu, Li, Huang, Chen, Chen, Luo, Guo, Jiang, Liu, Chen, Shen, Wang, Zheng, Zhao, Chen, Deng, Liu, Yan, Zhan, Wang, Xiao, Shi (bib110) 2020; 579
Wang, Zhang, Zhang, He, Zhu (bib59) 2020
Rivera-Figueroa, Santos, Simpson, Garg (bib40) 2020
Davis, Hutcheson, Mohan (bib151) 2011; 31
Del Valle, Kim-schulze, Hsin-hui, Beckmann, Nirenberg, Wang, Lavin, Swartz, Madduri, Stock, Marron, Xie, Patel, van Oekelen, Rahman, Kovatch, Aberg, Schadt, Jagannath, Mazumdar, Charney, Firpo-Betancourt, Mendu, Jhang, Reich, Sigel, Cordon-Cardo, Feldmann, Parekh, Merad, Gnjatic (bib78) 2020
Lucchese, Flöel (bib175) 2020; 19
Naugler, Sakurai, Kim, Maeda, Kim, Elsharkawy, Karin (bib162) 2007; 317
Ceribelli, Motta, De Santis, Ansari, Ridgway, Gershwin, Selmi (bib193) 2020; 109
Zulfiqar, Lorenzo-Villalba, Hassler, Andrès (bib29) 2020; 382
Ferro F, Elefante, Baldini, Bartoloni, Puxeddu, Talarico, Mosca (bib190) 2020; 38
Schulert, Grom (bib141) 2014; 28
Thevarajan, Nguyen, Koutsakos, Druce, Caly, van de Sandt, Jia, Nicholson, Catton, Cowie, Tong, Lewin, Kedzierska (bib109) 2020; 26
Letko, Marzi, Munster (bib62) 2020; 5
Kahlenberg, Thacker, Berthier, Cohen, Kretzler, Kaplan (bib55) 2011; 187
Robbiani, Gaebler, Muecksch, Lorenzi, Wang, Cho, Agudelo, Barnes, Gazumyan, Finkin, Hagglof, Oliveira, Viant, Hurley, Hoffmann, Millard, Kost, Cipolla, Gordon, Bianchini, Chen, Ramos, Patel, Dizon, Shimeliovich, Mendoza, Hartweger, Nogueira, Pack, Horowitz, Schmidt, Weisblum, Michailidis, Ashbrook, Waltari, Pak, Huey-Tubman, Koranda, Hoffman, West, Rice, Hatziioannou, Bjorkman, Bieniasz, Caskey, Nussenzweig (bib116) 2020
Xu, Shi, Wang, Zhang, Huang, Zhang, Liu, Zhao, Liu, Zhu, Tai, Bai, Gao, Song, Xia, Dong, Zhao, Wang (bib101) 2020; 8
Dostál, Newkirk, Duffy, Palečková, Bošák, Černá, Žd’árský, Zvárová (bib17) 1997; 815
Verdoni, Mazza, Gervasoni, Martelli, Ruggeri, Ciuffreda, Bonanomi, D’Antiga (bib39) 2020; 395
Zang, Gomez Castro, McCune, Zeng, Rothlauf, Sonnek, Liu, Brulois, Wang, Greenberg, Diamond, Ciorba, Whelan, Ding (bib67) 2020; 5
Raucci, Mansour, Casillo, Saviano, Caso, Scarpa, Mascolo, Iqbal, Maione (bib179) 2020; 19
Baggio (bib156) 2017; 39
McGonagle, McDermott (bib50) 2006; 3
Xiong, Liu, Cao, Wang, Guo, Jiang, Guo, Hu, Yang, Tang, Wu, Lin, Zhang, Zhang, Shi, Liu, Zhou, Lan, Chen (bib105) 2020; 9
Long, Liu, Deng, Wu, Deng, Chen, Liao, Qiu, Lin, Cai, Wang, Hu, Ren, Tang, Xu, Yu, Mo, Gong, Zhang, Tian, Hu, Zhang, Xiang, Du, Liu, Lang, Luo, Wu, Cui, Zhou, Zhu, Wang, Xue, Li, Wang, Li, Wang, Niu, Yang, Tang, Zhang, Liu, Li, Zhang, Zhang, Liu, Yuan, Li, Hu, Chen, Huang (bib7) 2020
Lopez, Kim, Pandey, Huang, DeLoughery (bib31) 2020
Liu, Li, Liu, Liang, Wang, Wang, Li, Tong, Yi, Zhao, Xiong, Guo, Tian, Luo, Yao, Pang, Shen, Peng, Liu, Zhang, Wu, Xu, Lu, Wang, Weng, Han, Zhu, Zhou, Zhou, Chen, Ye, Zhu, Wang, Zhou, He, He, Jie, Wei, Zhang, Lu, Wang, Zhang, Li, Zhou, Wang, Dittmer, Lu, Hu, Yang, Zheng (bib80) 2020; 55
Fafi-Kremer, Bruel, Madec, Grant, Tondeur, Grzelak, Staropoli, Anna, Souque, Mutter, Collongues, Bolle, Velay, Lefebvre, Mielcarek, Meyer, Rey, Charneau, Hoen, De Seze, Schwartz, Fontanet (bib113) 2020
Bao, Deng, Gao, Xiao, Liu, Xue, Lv, Liu, Yu, Xu, Qi, Qu, Li, Xiang, Yu, Gong, Liu, Wang, Wang, Song, Zhao, Han, Zhao, Liu, Wei, Qin (bib167) 2020
Liu, Xu, Zhang, Xuan, Yan, Pan, Yu, Zhang (bib70) 2020; 95
Xu, Han, Li, Sun, Wang, Fu, Zhou, Zheng, Yang, Li, Zhang, Pan, Wei (bib130) 2020; 117
Jones, Mills, Suarez, Hogan, Yeh, Bradley Segal, Nguyen, Barsh, Maskatia, Mathew (bib37) 2020
Crayne, Albeituni, Nichols, Cron (bib145) 2019; 10
Novelli, Barbati, Ceccarelli, Perricone, Spinelli, Alessandri, Valesini, Perricone, Conti (bib98) 2019; 28
Du, Yuan (bib8) 2020
Wang, Yang, Li, Wen, Zhang (bib126) 2020
Murt, Eskazan, Yılmaz, Ozkan, Ar (bib32) 2020
Matsubara, Ichiyama, Furukawa (bib183) 2005; 141
Alberti, Beretta, Piatti, Karantzoulis, Piatti, Santoro, Viganò, Giovannelli, Pirro, Montisano, Appollonio, Ferrarese (bib19) 2020; 7
Khoruts, Fraser (bib93) 2005; 98
(bib58) 2013
Atkinson, Petersen (bib173) 2020; 395
Fu, Cheng, Wu (bib120) 2020
Sarzi-Puttini, Giorgi, Sirotti, Marotto, Ardizzone, Rizzardini, Antinori (bib192) 2020; 38
Tay, Poh, Rénia, MacAry, Ng (bib6) 2020; 20
Xiang, Wang, He, Peng, Yang, Zhang, Zhou, Ye, Ma, Li, Wei, Cai, Ma (bib111) 2020
Zeng, Li, Huang, Wu, Dong, Xu (bib106) 2020
Cameron, Kelvin, Leon, Cameron, Ran, Xu, Chu, Danesh, Fang, Li, Anderson, Couch, Paquette, Fomukong, Kistner, Lauchart, Rowe, Harrod, Jonsson, Kelvin (bib166) 2012; 7
Aguiar, Erkan (bib178) 2013; 5
Croft, So, Duan, Soroosh (bib99) 2009; 229
Sungnak, Huang, Bécavin, Berg, Queen, Litvinukova, Talavera-López, Maatz, Reichart, Sampaziotis, Worlock, Yoshida, Barnes (bib65) 2020; 26
Rojas, Rodríguez, Monsalve, Acosta-Ampudia, Camacho, Gallo, Rojas-Villarraga, Ramírez-Santana, Díaz-Coronado, Manrique, Mantilla, Shoenfeld, Anaya (bib121) 2020; 19
Ellinghaus, Degenhardt, Bujanda, Buti, Albillos, Invernizzi, Fernandez, Prati, Baselli, Asselta, Grimsrud, Milani, Aziz, Kassens, May, Wendorff, Wienbrandt, Uellendahl-Werth, Zheng, Yi, de Pablo, Chercoles, Palom, Garcia-Fernandez, Rodriguez-Frias, Zanella, Bandera, Protti, Aghemo, de Nalda, Biondi, Caballero-Garralda, Gori, Tanck, Latiano, Fracanzani, Peschuck, Julia, Pesenti, Voza, Jimenez, Mateos, Jimenez, Quereda, Angelini, Cea, Solier, Pestana, Sandoval, Paraboschi, Navas, Ceriotti, Martinelli-Boneschi, Peyvandi, Blasi, Tellez, Blanco-Grau, Grasselli, Costantino, Cardamone, Foti, Aneli, Kurihara, ElAbd, My, Martin, Erdmann, Ferrusquia-Acosta, Garcia-Etxebarria, Izquierdo-Sanchez, Bettini, Terranova, Moreira, Santoro, Scudeller, Mesonero, Roade, Schaefer, Carrabba, Riveiro Barciela, Basso, Valsecchi, Hernandez-Tejero, Acosta-Herrera, D\textquoterightAngio, Baldini, Cazzaniga, Schulzky, Cecconi, Wittig, Ciccarelli, Rodriguez-Gandia, Bocciolone, Miozzo, Braun, Martinez, Palmieri, Faverio, Preatoni, Bonfanti, Omodei, Tentorio, Castro, Rodrigues, Blandino Ortiz, Roca, Gualtierotti, Nieto, Badalamenti, Marsal, Matullo, Pelusi, Monzani, Wesse, Pumarola, Rimoldi, Bosari, Albrecht, Peter, Gomez, D\textquoterightAmato, Duga, Banales, Hov, Folseraas, Valenti, Franke, Karlsen (bib60) 2020
Sharmeen, Elghawy, Zarlasht, Yao (bib138) 2020
Zuo, Yalavarthi, Shi, Gockman, Zuo, Madison, Blair, Weber, Barnes, Egeblad, Woods, Kanthi, Knight (bib4) 2020
Doria, Zen, Bettio, Gatto, Bassi, Nalotto, Ghirardello, Iaccarino, Punzi (bib51) 2012; 12
Gerfaud-Valentin, Jamilloux, Iwaz, Sève (bib155) 2014; 13
Gray, Westerhof, MacLeod (bib95) 2018; 154
Zhao, Qin, Zhang, Li, Liang, Sun, Xu, Dai, Li, Zhang, Peng, Feng, Li, Hu, Xiang, Ogg, Ho, McMichael, Jin, Knight, Dong, Zhang (bib84) 2020
Xu, Sun, Nie, Li, Kong, Liang, Hou, Huang, Li, Ma, Peng, Gao, Sh
Rivera-Figueroa (10.1016/j.jaut.2020.102506_bib40) 2020
Boyman (10.1016/j.jaut.2020.102506_bib90) 2009; 39
Wu (10.1016/j.jaut.2020.102506_bib124) 2020; 53
Castiblanco (10.1016/j.jaut.2020.102506_bib194) 2015; 16
Antoniou (10.1016/j.jaut.2020.102506_bib154) 2013
Fernandez-Cooke (10.1016/j.jaut.2020.102506_bib182) 2019; 14
Atkinson (10.1016/j.jaut.2020.102506_bib173) 2020; 395
Aguiar (10.1016/j.jaut.2020.102506_bib178) 2013; 5
Novelli (10.1016/j.jaut.2020.102506_bib98) 2019; 28
Toubiana (10.1016/j.jaut.2020.102506_bib42) 2020; 369
Wang (10.1016/j.jaut.2020.102506_bib108) 2020
Wang (10.1016/j.jaut.2020.102506_bib59) 2020
Braciale (10.1016/j.jaut.2020.102506_bib142) 2013; 255
Riphagen (10.1016/j.jaut.2020.102506_bib38) 2020; 395
Verdoni (10.1016/j.jaut.2020.102506_bib39) 2020; 395
Zhou (10.1016/j.jaut.2020.102506_bib110) 2020; 579
Chen (10.1016/j.jaut.2020.102506_bib169) 2020; 93
Schulze-Koops (10.1016/j.jaut.2020.102506_bib89) 2004; 6
Schulert (10.1016/j.jaut.2020.102506_bib141) 2014; 28
Knochelmann (10.1016/j.jaut.2020.102506_bib104) 2018; 15
Mehta (10.1016/j.jaut.2020.102506_bib132) 2020; 395
Cameron (10.1016/j.jaut.2020.102506_bib166) 2012; 7
Letko (10.1016/j.jaut.2020.102506_bib62) 2020; 5
Cantini (10.1016/j.jaut.2020.102506_bib49) 2020
Bomhof (10.1016/j.jaut.2020.102506_bib34) 2020
Gorse (10.1016/j.jaut.2020.102506_bib171) 2020; 92
Ellinghaus (10.1016/j.jaut.2020.102506_bib60) 2020
Zhang (10.1016/j.jaut.2020.102506_bib163) 2018; 15
Xiang (10.1016/j.jaut.2020.102506_bib111) 2020
(10.1016/j.jaut.2020.102506_bib58) 2013
Bin Dhuban (10.1016/j.jaut.2020.102506_bib146) 2019; 10
Perrone (10.1016/j.jaut.2020.102506_bib131) 2020
Ruan (10.1016/j.jaut.2020.102506_bib3) 2020; 46
Blanco-Melo (10.1016/j.jaut.2020.102506_bib76) 2020; 181
Ceribelli (10.1016/j.jaut.2020.102506_bib193) 2020; 109
Shimabukuro-Vornhagen (10.1016/j.jaut.2020.102506_bib127) 2018; 6
Du (10.1016/j.jaut.2020.102506_bib68) 2020; 201
Meng-Yuan (10.1016/j.jaut.2020.102506_bib63) 2020; 9
Mihai (10.1016/j.jaut.2020.102506_bib136) 2020; 79
Roussou (10.1016/j.jaut.2020.102506_bib159) 2011; 30
Liblau (10.1016/j.jaut.2020.102506_bib103) 2002; 17
Arnaud (10.1016/j.jaut.2020.102506_bib25) 2020; 131
Helms (10.1016/j.jaut.2020.102506_bib46) 2020; 46
Virani (10.1016/j.jaut.2020.102506_bib21) 2020; 20
Del Valle (10.1016/j.jaut.2020.102506_bib78) 2020
Harzallah (10.1016/j.jaut.2020.102506_bib44) 2020
Bullard (10.1016/j.jaut.2020.102506_bib174) 2020
Khoruts (10.1016/j.jaut.2020.102506_bib93) 2005; 98
Vojdani (10.1016/j.jaut.2020.102506_bib177) 2020; 217
WHO (10.1016/j.jaut.2020.102506_bib2) 2020
Son (10.1016/j.jaut.2020.102506_bib186) 2020; 369
Sharmeen (10.1016/j.jaut.2020.102506_bib138) 2020
Lucchese (10.1016/j.jaut.2020.102506_bib175) 2020; 19
Costello (10.1016/j.jaut.2020.102506_bib189) 2020
Scheidl (10.1016/j.jaut.2020.102506_bib23) 2020
Shi (10.1016/j.jaut.2020.102506_bib81) 2020
Ahn (10.1016/j.jaut.2020.102506_bib48) 2020; 30
Zhao (10.1016/j.jaut.2020.102506_bib84)
Rowley (10.1016/j.jaut.2020.102506_bib185) 2011; 203
Liu (10.1016/j.jaut.2020.102506_bib80) 2020; 55
Bloch (10.1016/j.jaut.2020.102506_bib117) 2020; 130
Kahlenberg (10.1016/j.jaut.2020.102506_bib55) 2011; 187
Sbidian (10.1016/j.jaut.2020.102506_bib57) 2019; 181
Zheng (10.1016/j.jaut.2020.102506_bib150) 2008; 180
Crayne (10.1016/j.jaut.2020.102506_bib145) 2019; 10
Mazzoni (10.1016/j.jaut.2020.102506_bib75) 2020
Thevarajan (10.1016/j.jaut.2020.102506_bib109) 2020; 26
Xu (10.1016/j.jaut.2020.102506_bib112) 2020
Fafi-Kremer (10.1016/j.jaut.2020.102506_bib113) 2020
Baggio (10.1016/j.jaut.2020.102506_bib156) 2017; 39
Ferro F (10.1016/j.jaut.2020.102506_bib190) 2020; 38
Crosslin (10.1016/j.jaut.2020.102506_bib158) 2011; 8
Liu (10.1016/j.jaut.2020.102506_bib77) 2020
Coen (10.1016/j.jaut.2020.102506_bib22) 2020
Franco (10.1016/j.jaut.2020.102506_bib184) 2010; 43
Tanaka (10.1016/j.jaut.2020.102506_bib129) 2016; 8
Naugler (10.1016/j.jaut.2020.102506_bib162) 2007; 317
Zulfiqar (10.1016/j.jaut.2020.102506_bib29) 2020; 382
Zhang (10.1016/j.jaut.2020.102506_bib69) 2020
Chen (10.1016/j.jaut.2020.102506_bib153) 2013; 15
Clay (10.1016/j.jaut.2020.102506_bib168) 2012; 86
Sarzi-Puttini (10.1016/j.jaut.2020.102506_bib192) 2020; 38
Ortona (10.1016/j.jaut.2020.102506_bib161) 2015; 1
Singh (10.1016/j.jaut.2020.102506_bib149) 2010
Wu (10.1016/j.jaut.2020.102506_bib170) 2007; 13
Zhou (10.1016/j.jaut.2020.102506_bib73) 2020; 27
Fu (10.1016/j.jaut.2020.102506_bib120) 2020
Pacheco (10.1016/j.jaut.2020.102506_bib11) 2019; 103
Toscano (10.1016/j.jaut.2020.102506_bib20) 2020
Mathew (10.1016/j.jaut.2020.102506_bib85) 2020
Zeng (10.1016/j.jaut.2020.102506_bib106) 2020
GeurtsvanKessel (10.1016/j.jaut.2020.102506_bib114) 2020
Puelles (10.1016/j.jaut.2020.102506_bib64) 2020
Dostál (10.1016/j.jaut.2020.102506_bib17) 1997; 815
Patterson (10.1016/j.jaut.2020.102506_bib83) 2020
Behrens (10.1016/j.jaut.2020.102506_bib125) 2017; 69
Quintero (10.1016/j.jaut.2020.102506_bib160) 2012; 38
Rawlings (10.1016/j.jaut.2020.102506_bib56) 2012; 12
Teuwen (10.1016/j.jaut.2020.102506_bib87) 2020
Qin (10.1016/j.jaut.2020.102506_bib71) 2020
Zheng (10.1016/j.jaut.2020.102506_bib72) 2020; 17
Ottaviani (10.1016/j.jaut.2020.102506_bib27) 2020; 41
Maeda (10.1016/j.jaut.2020.102506_bib91) 2005; 106
Long (10.1016/j.jaut.2020.102506_bib7) 2020
Sungnak (10.1016/j.jaut.2020.102506_bib65) 2020; 26
Ramos-Casals (10.1016/j.jaut.2020.102506_bib143) 2014; 383
Li (10.1016/j.jaut.2020.102506_bib152) 2020; 58
Theofilopoulos (10.1016/j.jaut.2020.102506_bib94) 2001; 108
Liu (10.1016/j.jaut.2020.102506_bib119) 2019; 4
Xu (10.1016/j.jaut.2020.102506_bib101) 2020; 8
van de Veerdonk (10.1016/j.jaut.2020.102506_bib88) 2020; 9
Smatti (10.1016/j.jaut.2020.102506_bib9) 2019; 11
Luo (10.1016/j.jaut.2020.102506_bib47) 2020
Zhou (10.1016/j.jaut.2020.102506_bib74) 2020
Lokman (10.1016/j.jaut.2020.102506_bib61) 2020
Raucci (10.1016/j.jaut.2020.102506_bib179) 2020; 19
Seydoux (10.1016/j.jaut.2020.102506_bib118) 2020
Sethuraman (10.1016/j.jaut.2020.102506_bib5) 2020; 323
Zuo (10.1016/j.jaut.2020.102506_bib4) 2020
Shamsizadeh (10.1016/j.jaut.2020.102506_bib181) 2014; 7
Moutsopoulos (10.1016/j.jaut.2020.102506_bib135) 2020
Gutiérrez-Ortiz (10.1016/j.jaut.2020.102506_bib26) 2020
Juliao Caamaño (10.1016/j.jaut.2020.102506_bib24) 2020
Zang (10.1016/j.jaut.2020.102506_bib67) 2020; 5
Davis (10.1016/j.jaut.2020.102506_bib151) 2011; 31
Wouters (10.1016/j.jaut.2020.102506_bib18) 1988; 47
Lazarian (10.1016/j.jaut.2020.102506_bib30) 2020
Sanderson (10.1016/j.jaut.2020.102506_bib15) 2017; 114
Jones (10.1016/j.jaut.2020.102506_bib37) 2020
Rigamonti (10.1016/j.jaut.2020.102506_bib140) 2020
Gerfaud-Valentin (10.1016/j.jaut.2020.102506_bib155) 2014; 13
Bao (10.1016/j.jaut.2020.102506_bib167) 2020
Murt (10.1016/j.jaut.2020.102506_bib32) 2020
Tay (10.1016/j.jaut.2020.102506_bib6) 2020; 20
Zhang (10.1016/j.jaut.2020.102506_bib43) 2020; 382
Belhadjer (10.1016/j.jaut.2020.102506_bib41) 2020
Generali (10.1016/j.jaut.2020.102506_bib52) 2018; 17
Yang (10.1016/j.jaut.2020.102506_bib82) 2020
Anna Ruggieri (10.1016/j.jaut.2020.102506_bib164) 2020; 6
Tan (10.1016/j.jaut.2020.102506_bib92) 2020; 5
Nathan (10.1016/j.jaut.2020.102506_bib36) 2020; 395
Chen (10.1016/j.jaut.2020.102506_bib35) 2020
Suthar (10.1016/j.jaut.2020.102506_bib115) 2020
Ramos-Casals (10.1016/j.jaut.2020.102506_bib14) 2005; 84
McGonagle (10.1016/j.jaut.2020.102506_bib50) 2006; 3
Huang (10.1016/j.jaut.2020.102506_bib123) 2020; 395
Du (10.1016/j.jaut.2020.102506_bib8) 2020
Jin (10.1016/j.jaut.2020.102506_bib165) 2020; 8
O'Sullivan (10.1016/j.jaut.2020.102506_bib147) 2006; 176
Joyner (10.1016/j.jaut.2020.102506_bib122) 2020
Lopez (10.1016/j.jaut.2020.102506_bib31) 2020
Devarajan (10.1016/j.jaut.2020.102506_bib96) 2013; 57
Alberti (10.1016/j.jaut.2020.102506_bib19) 2020; 7
Xu (10.1016/j.jaut.2020.102506_bib130) 2020; 117
Gray (10.1016/j.jaut.2020.102506_bib95) 2018; 154
Kanduc (10.1016/j.jaut.2020.102506_bib176) 2020; 215
Ahmed (10.1016/j.jaut.2020.102506_bib33) 2020
Touret (10.1016/j.jaut.2020.102506_bib191) 2020; 177
Ghiringhelli (10.1016/j.jaut.2020.102506_bib54) 2009; 15
Caso (10.1016/j.jaut.2020.102506_bib53) 2018; 37
Dinkin (10.1016/j.jaut.2020.102506_bib28) 2020
Chu (10.1016/j.jaut.2020.102506_bib107) 2016; 213
Diao (10.1016/j.jaut.2020.102506_bib79) 2020; 11
Giamarellos-Bourboulis (10.1016/j.jaut.2020.102506_bib133) 2020; 27
Channappanavar (10.1016/j.jaut.2020.102506_bib86) 2017; 39
(10.1016/j.jaut.2020.102506_bib172) 2020
Pouchot (10.1016/j.jaut.2020.102506_bib148) 2012; 26
Deane (10.1016/j.jaut.2020.102506_bib144) 2010; 153
Rojas (10.1016/j.jaut.2020.102506_bib10) 2018; 95
Wang (10.1016/j.jaut.2020.102506_bib102) 2020; 221
Robbiani (10.1016/j.jaut.2020.102506_bib116) 2020
Liu (10.1016/j.jaut.2020.102506_bib70) 2020; 95
Chen (10.1016/j.jaut.2020.102506_bib16) 2015; 34
Behrens (10.1016/j.jaut.2020.102506_bib128) 2019
Doria (10.1016/j.jaut.2020.102506_bib51) 2012; 12
Duret (10.1016/j.jaut.2020.102506_bib134) 2020
Filippi (10.1016/j.jaut.2020.102506_bib12) 2008; 57
Bowles (10.1016/j.jaut.2020.102506_bib45) 2020
Matsubara (10.1016/j.jaut.2020.102506_bib183) 2005; 141
Rojas (10.1016/j.jaut.2020.102506_bib121) 2020; 19
Xiong (10.1016/j.jaut.2020.102506_bib105) 2020; 9
Cacoub (10.1016/j.jaut.2020.102506_bib13) 2014; 73
Emmi (10.1016/j.jaut.2020.102506_bib139) 2020; 19
Hoffmann (10.1016/j.jaut.2020.102506_bib66) 2020; 181
Zhu (10.1016/j.jaut.2020.102506_bib100) 2007; 109
Guilpain (10.1016/j.jaut.2020.102506_bib137) 2020
Baig (10.1016/j.jaut.2020.102506_bib188) 2020; 11
Zhu (10.1016/j.jaut.2020.102506_bib1) 2020; 382
Galván Casas (10.1016/j.jaut.2020.102506_bib180) 2020
Croft (10.1016/j.jaut.2020.102506_bib99) 2009; 229
Wang (10.1016/j.jaut.2020.102506_bib126) 2020
Rodríguez (10.1016/j.jaut.2020.102506_bib187) 2018; 15
Braun (10.1016/j.jaut.2020.102506_bib97) 2020
Angela Tincani (10.1016/j.jaut.2020.102506_bib157) 2018; 4
References_xml – volume: 14
  year: 2019
  ident: bib182
  article-title: Epidemiological and clinical features of Kawasaki disease in Spain over 5 years and risk factors for aneurysm development. (2011-2016): KAWA-RACE study group
  publication-title: PloS One
– volume: 141
  start-page: 381
  year: 2005
  end-page: 387
  ident: bib183
  article-title: Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease
  publication-title: Clin. Exp. Immunol.
– year: 2020
  ident: bib64
  article-title: Multiorgan and renal tropism of SARS-CoV-2
  publication-title: N. Engl. J. Med.
– year: 2020
  ident: bib7
  article-title: Antibody responses to SARS-CoV-2 in patients with COVID-19
  publication-title: Nat. Med.
– year: 2020
  ident: bib26
  article-title: Miller Fisher Syndrome and polyneuritis cranialis in COVID-19
  publication-title: Neurology
– year: 2013
  ident: bib58
  publication-title: Autoimmunity: from Bench to Bedside
– year: 2020
  ident: bib189
  article-title: Cranial neuropathies and COVID-19: neurotropism and autoimmunity
  publication-title: Neurology
– volume: 177
  start-page: 104762
  year: 2020
  ident: bib191
  article-title: Of chloroquine and COVID-19
  publication-title: Antivir. Res.
– volume: 15
  start-page: R39
  year: 2013
  ident: bib153
  article-title: Involvement of TLR7 MyD88-dependent signaling pathway in the pathogenesis of adult-onset Still's disease
  publication-title: Arthritis Res. Ther.
– volume: 19
  start-page: 102575
  year: 2020
  ident: bib139
  article-title: SARS-CoV-2 infection among patients with systemic autoimmune diseases
  publication-title: Autoimmun. Rev.
– volume: 19
  start-page: 102554
  year: 2020
  ident: bib121
  article-title: Convalescent plasma in Covid-19: possible mechanisms of action
  publication-title: Autoimmun. Rev.
– start-page: 1
  year: 2020
  end-page: 3
  ident: bib87
  article-title: COVID-19: the vasculature unleashed
  publication-title: Nat. Rev. Immunol.
– year: 2020
  ident: bib120
  article-title: Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools
  publication-title: Virol. Sin.
– volume: 3
  start-page: e297
  year: 2006
  ident: bib50
  article-title: A proposed classification of the immunological diseases
  publication-title: PLoS Med.
– volume: 131
  start-page: 1652
  year: 2020
  end-page: 1654
  ident: bib25
  article-title: Post SARS-CoV-2 guillain-barré syndrome
  publication-title: Clin. Neurophysiol.
– volume: 20
  year: 2020
  ident: bib21
  article-title: Guillain-Barré Syndrome associated with SARS-CoV-2 infection
  publication-title: IDCases
– volume: 109
  start-page: 102442
  year: 2020
  ident: bib193
  article-title: Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
  publication-title: J. Autoimmun.
– volume: 7
  year: 2012
  ident: bib166
  article-title: Lack of innate Interferon responses during SARS coronavirus infection in a vaccination and reinfection ferret model
  publication-title: PloS One
– volume: 395
  start-page: 1339
  year: 2020
  end-page: 1340
  ident: bib173
  article-title: SARS-CoV-2 shedding and infectivity
  publication-title: Lancet
– volume: 19
  start-page: 102556
  year: 2020
  ident: bib175
  article-title: Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons
  publication-title: Autoimmun. Rev.
– volume: 103
  start-page: 102301
  year: 2019
  ident: bib11
  article-title: Bystander activation and autoimmunity
  publication-title: J. Autoimmun.
– volume: 57
  start-page: 2863
  year: 2008
  end-page: 2871
  ident: bib12
  article-title: Viral trigger for type 1 diabetes: pros and cons
  publication-title: Diabetes
– year: 2020
  ident: bib82
  article-title: Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome
  publication-title: MedRxiv
– volume: 815
  start-page: 334
  year: 1997
  end-page: 337
  ident: bib17
  article-title: Herpes viruses in multicase families with rheumatoid arthritis and systemic lupus erythematosus
  publication-title: Ann. N. Y. Acad. Sci.
– volume: 10
  year: 2019
  ident: bib145
  article-title: The immunology of macrophage activation syndrome
  publication-title: Front. Immunol.
– volume: 5
  start-page: 33
  year: 2020
  ident: bib92
  article-title: Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study
  publication-title: Signal Transduct. Target. Theroy
– volume: 5
  start-page: 305
  year: 2013
  end-page: 314
  ident: bib178
  article-title: Catastrophic antiphospholipid syndrome: how to diagnose a rare but highly fatal disease
  publication-title: Ther. Adv. Musculoskelet. Disease
– volume: 108
  start-page: 335
  year: 2001
  end-page: 340
  ident: bib94
  article-title: T cell homeostasis and systemic autoimmunity
  publication-title: J. Clin. Invest.
– volume: 382
  start-page: e38
  year: 2020
  ident: bib43
  article-title: Coagulopathy and antiphospholipid antibodies in patients with covid-19
  publication-title: N. Engl. J. Med.
– year: 2020
  ident: bib134
  article-title: Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept
  publication-title: Ann. Rheum. Dis.
– volume: 12
  start-page: 282
  year: 2012
  end-page: 294
  ident: bib56
  article-title: Integration of B cell responses through Toll-like receptors and antigen receptors
  publication-title: Nat. Rev. Immunol.
– year: 2020
  ident: bib83
  article-title: Disruption of the CCL5/RANTES-CCR5 pathway restores immune homeostasis and reduces plasma viral load in critical COVID-19
  publication-title: MedRxiv
– volume: 39
  start-page: 196
  year: 2017
  end-page: 198
  ident: bib156
  article-title: Gender Medicine: a interdisciplinary approach to medicine
  publication-title: G. Ital. Med. Lav. Ergon.
– year: 2020
  ident: bib34
  article-title: COVID-19-associated immune thrombocytopenia
  publication-title: Br. J. Haematol.
– volume: 10
  start-page: 1
  year: 2019
  end-page: 13
  ident: bib146
  article-title: Signaling through gp130 compromises suppressive function in human FOXP3+ regulatory T cells
  publication-title: Front. Immunol.
– year: 2020
  ident: bib140
  article-title: Rates of symptomatic SARS-CoV-2 infection in patients with autoimmune liver diseases in Northern Italy: a telemedicine study
  publication-title: Clin. Gastroenterol. Hepatol.
– volume: 28
  start-page: 621
  year: 2019
  end-page: 628
  ident: bib98
  article-title: CD44v3 and CD44v6 isoforms on T cells are able to discriminate different disease activity degrees and phenotypes in systemic lupus erythematosus patients
  publication-title: Lupus
– volume: 382
  start-page: e43
  year: 2020
  ident: bib29
  article-title: Immune thrombocytopenic purpura in a patient with covid-19
  publication-title: N. Engl. J. Med.
– volume: 46
  start-page: 1089
  year: 2020
  end-page: 1098
  ident: bib46
  article-title: High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
  publication-title: Intensive Care Med.
– year: 2020
  ident: bib23
  article-title: Guillain‐Barre syndrome during SARS‐CoV ‐2 pandemic: a case report and review of recent literature
  publication-title: J. Peripher. Nerv. Syst.
– volume: 17
  start-page: 533
  year: 2020
  end-page: 535
  ident: bib72
  article-title: Functional exhaustion of antiviral lymphocytes in COVID-19 patients
  publication-title: Cell. Mol. Immunol.
– volume: 8
  start-page: 152
  year: 2020
  ident: bib165
  article-title: Gender differences in patients with COVID-19: focus on severity and mortality
  publication-title: Front. Public. Health
– volume: 37
  start-page: 2305
  year: 2018
  end-page: 2321
  ident: bib53
  article-title: From autoinflammation to autoimmunity: old and recent findings
  publication-title: Clin. Rheumatol.
– volume: 16
  start-page: 47
  year: 2015
  end-page: 59
  ident: bib194
  article-title: Genetics and vaccines in the era of personalized medicine
  publication-title: Curr. Genom.
– volume: 15
  start-page: 458
  year: 2018
  end-page: 469
  ident: bib104
  article-title: When worlds collide: Th17 and Treg cells in cancer and autoimmunity
  publication-title: Cell. Mol. Immunol.
– volume: 43
  start-page: 317
  year: 2010
  end-page: 324
  ident: bib184
  article-title: Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease
  publication-title: Autoimmunity
– volume: 58
  start-page: 71
  year: 2020
  end-page: 81
  ident: bib152
  article-title: Autoinflammatory pathogenesis and targeted therapy for adult-onset Still's disease
  publication-title: Clin. Rev. Allergy Immunol.
– volume: 17
  start-page: 1
  year: 2002
  end-page: 6
  ident: bib103
  article-title: Autoreactive CD8 T cells in organ-specific autoimmunity
  publication-title: Immunity
– volume: 395
  start-page: 497
  year: 2020
  end-page: 506
  ident: bib123
  article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
  publication-title: Lancet
– volume: 323
  start-page: 2249
  year: 2020
  end-page: 2251
  ident: bib5
  article-title: Interpreting diagnostic tests for SARS-CoV-2
  publication-title: J. Am. Med. Assoc.
– volume: 12
  start-page: 22
  year: 2012
  end-page: 30
  ident: bib51
  article-title: Autoinflammation and autoimmunity: bridging the divide
  publication-title: Autoimmun. Rev.
– year: 2020
  ident: bib84
  article-title: Longitudinal COVID-19 profiling associates IL-1Ra and IL-10 with disease severity and RANTES with mild disease, JCI Insight
– volume: 98
  start-page: 23
  year: 2005
  end-page: 31
  ident: bib93
  article-title: A causal link between lymphopenia and autoimmunity
  publication-title: Immunol. Lett.
– year: 2020
  ident: bib20
  article-title: Guillain–barré syndrome associated with SARS-CoV-2
  publication-title: N. Engl. J. Med.
– start-page: 26138
  year: 2020
  ident: bib32
  article-title: COVID‐19 presenting with immune thrombocytopenia: a case report and review of the literature
  publication-title: J. Med. Virol.
– volume: 109
  start-page: 4882
  year: 2007
  end-page: 4889
  ident: bib100
  article-title: CD137 stimulation delivers an antigen-independent growth signal for T lymphocytes with memory phenotype
  publication-title: Blood
– volume: 369
  year: 2020
  ident: bib42
  article-title: Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study
  publication-title: BMJ
– volume: 53
  start-page: 368
  year: 2020
  end-page: 370
  ident: bib124
  article-title: TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor Fedratinib
  publication-title: J. Microbiol. Immunol. Infect.
– year: 2020
  ident: bib180
  article-title: Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases
  publication-title: Br. J. Dermatol.
– year: 2020
  ident: bib44
  article-title: Lupus anticoagulant is frequent in patients with Covid‐19
  publication-title: J. Thromb. Haemostasis
– year: 2020
  ident: bib77
  article-title: Elevated plasma level of selective cytokines in COVID-19 patients reflect viral load and lung injury
  publication-title: Natl. Sci. Rev.
– year: 2020
  ident: bib8
  article-title: Mathematical modeling of interaction between innate and adaptive immune responses in COVID‐19 and implications for viral pathogenesis
  publication-title: J. Med. Virol.
– volume: 69
  start-page: 1135
  year: 2017
  end-page: 1143
  ident: bib125
  article-title: Review: cytokine storm syndrome: looking toward the precision medicine era
  publication-title: Arthritis Rheum.
– volume: 176
  start-page: 7278
  year: 2006
  end-page: 7287
  ident: bib147
  article-title: IL-1β breaks tolerance through expansion of CD25 + effector T cells
  publication-title: J. Immunol.
– year: 2020
  ident: bib41
  article-title: Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic
  publication-title: Circulation
– volume: 1
  start-page: 45
  year: 2015
  end-page: 50
  ident: bib161
  article-title: Sex hormones and gender disparity in immunity and autoimmunity
  publication-title: Italy J. Gender-Specifi c Med.
– volume: 86
  start-page: 4234
  year: 2012
  end-page: 4244
  ident: bib168
  article-title: Primary severe acute respiratory syndrome coronavirus infection limits replication but not lung inflammation upon homologous rechallenge
  publication-title: J. Virol.
– volume: 181
  start-page: 1036
  year: 2020
  end-page: 1045.e9
  ident: bib76
  article-title: Imbalanced host response to SARS-CoV-2 drives development of COVID-19
  publication-title: Cell
– start-page: 1
  year: 2020
  end-page: 29
  ident: bib131
  article-title: Protocol Title : " Multicenter Study on the Efficacy and Tolerability of Tocilizumab in the Treatment of Patients with COVID-19 Pneumonia
– year: 2020
  ident: bib40
  article-title: Incomplete Kawasaki Disease in a Child with Covid-19
– volume: 47
  start-page: 764
  year: 1988
  end-page: 767
  ident: bib18
  article-title: Adult onset Still's disease and viral infections
  publication-title: Ann. Rheum. Dis.
– volume: 13
  start-page: 1562
  year: 2007
  end-page: 1564
  ident: bib170
  article-title: Duration of antibody responses after severe acute respiratory syndrome
  publication-title: Emerg. Infect. Dis.
– volume: 9
  start-page: 45
  year: 2020
  ident: bib63
  article-title: Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues
  publication-title: Infect. Disease Poverty.
– volume: 229
  start-page: 173
  year: 2009
  end-page: 191
  ident: bib99
  article-title: The significance of OX40 and OX40L to T-cell biology and immune disease
  publication-title: Immunol. Rev.
– start-page: 2
  year: 2020
  end-page: 4
  ident: bib108
  article-title: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion
  publication-title: Cell. Mol. Immunol.
– year: 2020
  ident: bib60
  article-title: The ABO blood group locus and a chromosome 3 gene cluster associate with SARS-CoV-2 respiratory failure in an Italian-Spanish genome-wide association analysis
  publication-title: MedRxiv
– volume: 213
  start-page: 904
  year: 2016
  end-page: 914
  ident: bib107
  article-title: Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways
  publication-title: J. Infect. Dis.
– volume: 181
  start-page: 271
  year: 2020
  end-page: 280
  ident: bib66
  article-title: SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor
  publication-title: Cell
– year: 2020
  ident: bib172
  article-title: Findings from Investigation and Analysis of Re-positive Cases
– volume: 20
  start-page: 363
  year: 2020
  end-page: 374
  ident: bib6
  article-title: The trinity of COVID-19: immunity, inflammation and intervention
  publication-title: Nat. Rev. Immunol.
– volume: 130
  start-page: 2757
  year: 2020
  end-page: 2765
  ident: bib117
  article-title: Deployment of convalescent plasma for the prevention and treatment of COVID-19
  publication-title: J. Clin. Invest.
– year: 2020
  ident: bib115
  article-title: Rapid generation of neutralizing antibody responses in COVID-19 patients
  publication-title: Cell Rep. Med.
– year: 2020
  ident: bib37
  article-title: COVID-19 and Kawasaki disease: novel virus and novel case
  publication-title: Hosp. Pediatr.
– volume: 95
  start-page: 183
  year: 2020
  end-page: 191
  ident: bib70
  article-title: Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression
  publication-title: Int. J. Infect. Dis.
– volume: 8
  start-page: 420
  year: 2020
  end-page: 422
  ident: bib101
  article-title: Pathological findings of COVID-19 associated with acute respiratory distress syndrome
  publication-title: Lancet Respir. Med.
– year: 2020
  ident: bib137
  article-title: Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia
  publication-title: Ann. Rheum. Dis.
– year: 2020
  ident: bib31
  article-title: Simultaneous onset of COVID‐19 and autoimmune haemolytic anaemia
  publication-title: Br. J. Haematol.
– volume: 6
  start-page: 49
  year: 2020
  end-page: 50
  ident: bib164
  article-title: Gender differences in COVID-19: some open questions
  publication-title: Italy. J. Gender-Specific Med.
– volume: 382
  start-page: 727
  year: 2020
  end-page: 733
  ident: bib1
  article-title: A novel coronavirus from patients with pneumonia in China, 2019
  publication-title: N. Engl. J. Med.
– volume: 30
  start-page: 313
  year: 2020
  end-page: 324
  ident: bib48
  article-title: Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19)
  publication-title: J. Microbiol. Biotechnol.
– volume: 30
  start-page: 121
  year: 2011
  end-page: 127
  ident: bib159
  article-title: Spondyloarthritis in women: differences in disease onset, clinical presentation, and Bath Ankylosing Spondylitis Disease Activity and Functional indices (BASDAI and BASFI) between men and women with spondyloarthritides
  publication-title: Clin. Rheumatol.
– volume: 15
  start-page: 206
  year: 2018
  ident: bib163
  article-title: The novel estrogenic receptor GPR30 alleviates ischemic injury by inhibiting TLR4-mediated microglial inflammation
  publication-title: J. Neuroinflammation
– volume: 317
  start-page: 121
  year: 2007
  end-page: 124
  ident: bib162
  article-title: Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production
  publication-title: Science
– year: 2020
  ident: bib118
  article-title: Analysis of a SARS-CoV-2 infected individual reveals development of potent neutralizing antibodies to distinct epitopes with limited somatic mutation
  publication-title: Immunity
– volume: 31
  start-page: 781
  year: 2011
  end-page: 789
  ident: bib151
  article-title: The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus
  publication-title: J. Interferon Cytokine Res.
– volume: 11
  start-page: 762
  year: 2019
  ident: bib9
  article-title: Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms
  publication-title: Viruses
– year: 2020
  ident: bib22
  article-title: Guillain-Barré syndrome as a complication of SARS-CoV-2 infection
  publication-title: Brain Behav. Immun.
– year: 2010
  ident: bib149
  article-title: Tocilizumab for rheumatoid arthritis
  publication-title: Cochrane Database Syst. Rev.
– volume: 93
  start-page: 297
  year: 2020
  end-page: 299
  ident: bib169
  article-title: Recurrence of positive SARS-CoV-2 RNA in COVID-19: a case report
  publication-title: Int. J. Infect. Dis.
– year: 2020
  ident: bib81
  article-title: Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China
  publication-title: MedRxiv
– volume: 57
  start-page: 12
  year: 2013
  end-page: 22
  ident: bib96
  article-title: Autoimmune effector memory T cells: the bad and the good
  publication-title: Immunol. Res.
– year: 2020
  ident: bib116
  article-title: Convergent antibody responses to SARS-CoV-2 infection in convalescent individuals
  publication-title: BioRxiv
– year: 2020
  ident: bib74
  article-title: Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients
  publication-title: Natl. Sci. Rev.
– volume: 7
  start-page: e741
  year: 2020
  ident: bib19
  article-title: Guillain-Barré syndrome related to COVID-19 infection
  publication-title: Neurol. Neuroimmunol. Neuroinflammation.
– volume: 215
  start-page: 108426
  year: 2020
  ident: bib176
  article-title: On the molecular determinants of the SARS-CoV-2 attack
  publication-title: Clin. Immunol.
– volume: 8
  start-page: 365
  year: 2011
  end-page: 371
  ident: bib158
  article-title: Sex differences in disease severity among patients with systemic lupus erythematosus
  publication-title: Gend. Med.
– volume: 13
  start-page: 708
  year: 2014
  end-page: 722
  ident: bib155
  article-title: Adult-onset Still's disease
  publication-title: Autoimmun. Rev.
– year: 2020
  ident: bib35
  article-title: Sudden severe thrombocytopenia in a patient in the recovery stage of COVID-19
  publication-title: Lancet Haematol.
– volume: 395
  start-page: 1771
  year: 2020
  end-page: 1778
  ident: bib39
  article-title: An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study
  publication-title: Lancet
– volume: 180
  start-page: 7112
  year: 2008
  end-page: 7116
  ident: bib150
  article-title: Cutting edge: foxp3 + CD4 + CD25 + regulatory T cells induced by IL-2 and TGF-β are resistant to Th17 conversion by IL-6
  publication-title: J. Immunol.
– start-page: 16769
  year: 2020
  ident: bib33
  article-title: Thrombocytopenia as an initial manifestation of COVID‐19; case series and literature review
  publication-title: Br. J. Haematol.
– volume: 4
  year: 2019
  ident: bib119
  article-title: Anti–spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection
  publication-title: JCI Insight
– year: 2020
  ident: bib114
  article-title: Towards the next phase: evaluation of serological assays for diagnostics and exposure assessment
  publication-title: MedRxiv
– volume: 19
  start-page: 102572
  year: 2020
  ident: bib179
  article-title: Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms
  publication-title: Autoimmun. Rev.
– volume: 154
  start-page: 574
  year: 2018
  end-page: 581
  ident: bib95
  article-title: The roles of resident, central and effector memory CD4 T-cells in protective immunity following infection or vaccination
  publication-title: Immunology
– volume: 4
  start-page: e79
  year: 2018
  end-page: e82
  ident: bib157
  article-title: Gender differences in rheumatology and the point of view of the Italian Society for Rheumatology (SIR)
  publication-title: Italy J. Gender-Specific Med.
– volume: 26
  start-page: 453
  year: 2020
  end-page: 455
  ident: bib109
  article-title: Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19
  publication-title: Nat. Med.
– volume: 106
  start-page: 879
  year: 2005
  end-page: 885
  ident: bib91
  article-title: IL-6 blocks a discrete early step in lymphopoiesis
  publication-title: Blood
– start-page: 197
  year: 2019
  end-page: 207
  ident: bib128
  article-title: Cytokines in cytokine storm syndrome
  publication-title: Cytokine Storm Syndr.
– volume: 203
  start-page: 1021
  year: 2011
  end-page: 1030
  ident: bib185
  article-title: Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a “new” virus associated with Kawasaki disease
  publication-title: J. Infect. Dis.
– year: 2020
  ident: bib106
  article-title: Mortality of COVID-19 is associated with cellular immune function compared to immune function in Chinese han population
  publication-title: MedRxiv
– volume: 7
  year: 2014
  ident: bib181
  article-title: Clinical and epidemiological characteristics of Kawasaki disease
  publication-title: Jundishapur J. Microbiol.
– volume: 187
  start-page: 6143
  year: 2011
  end-page: 6156
  ident: bib55
  article-title: Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus
  publication-title: J. Immunol.
– year: 2020
  ident: bib2
  article-title: Coronavirus Disease 2019 (COVID-19)situation Report – 52
– volume: 11
  start-page: 1
  year: 2020
  end-page: 7
  ident: bib79
  article-title: Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)
  publication-title: Front. Immunol.
– year: 2020
  ident: bib28
  article-title: COVID-19 presenting with ophthalmoparesis from cranial nerve palsy
  publication-title: Neurology
– volume: 5
  year: 2020
  ident: bib67
  article-title: TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes
  publication-title: Sci. Immunol.
– year: 2020
  ident: bib78
  article-title: An inflammatory cytokine signature helps predict COVID-19 severity and death
  publication-title: MedRxiv
– start-page: 1
  year: 2020
  end-page: 23
  ident: bib111
  article-title: Antibody detection and dynamic characteristics in patients with COVID-19
  publication-title: Clin. Infect. Dis.
– volume: 26
  start-page: 681
  year: 2020
  end-page: 687
  ident: bib65
  article-title: SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
  publication-title: Nat. Med.
– year: 2020
  ident: bib49
  article-title: Baricitinib therapy in COVID-19: a pilot study on safety and clinical impact
  publication-title: J. Infect.
– volume: 579
  start-page: 270
  year: 2020
  end-page: 273
  ident: bib110
  article-title: A pneumonia outbreak associated with a new coronavirus of probable bat origin
  publication-title: Nature
– volume: 95
  start-page: 100
  year: 2018
  end-page: 123
  ident: bib10
  article-title: Molecular mimicry and autoimmunity
  publication-title: J. Autoimmun.
– volume: 55
  start-page: 102763
  year: 2020
  ident: bib80
  article-title: Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
  publication-title: EBioMedicine
– volume: 26
  start-page: 477
  year: 2012
  end-page: 487
  ident: bib148
  article-title: Biological treatment in adult-onset Still's disease
  publication-title: Best Pract. Res. Clin. Rheumatol.
– volume: 41
  start-page: 1351
  year: 2020
  end-page: 1354
  ident: bib27
  article-title: Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital
  publication-title: Neurol. Sci.
– year: 2020
  ident: bib174
  article-title: Predicting infectious SARS-CoV-2 from diagnostic samples
  publication-title: Clin. Infect. Dis.
– year: 2020
  ident: bib4
  article-title: Neutrophil extracellular traps (NETs) as markers of disease severity in COVID-19
  publication-title: MedRxiv
– year: 2020
  ident: bib112
  article-title: Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China
  publication-title: Nat. Med.
– volume: 38
  start-page: 337
  year: 2020
  end-page: 342
  ident: bib192
  article-title: COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?
  publication-title: Clin. Exp. Rheumatol.
– volume: 181
  start-page: 1304
  year: 2019
  end-page: 1306
  ident: bib57
  article-title: Respiratory virus infection triggers acute psoriasis flares across different clinical subtypes and genetic backgrounds
  publication-title: Br. J. Dermatol.
– volume: 92
  start-page: 512
  year: 2020
  end-page: 517
  ident: bib171
  article-title: Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus‐associated illnesses
  publication-title: J. Med. Virol.
– year: 2020
  ident: bib71
  article-title: Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in wuhan, China
  publication-title: Clin. Infect. Dis.
– start-page: 1
  year: 2013
  end-page: 4
  ident: bib154
  article-title: Adult onset Still's disease: a case report with a rare clinical manifestation and pathophysiological correlations
  publication-title: Case Rep. Med.
– volume: 73
  start-page: 24
  year: 2014
  end-page: 30
  ident: bib13
  article-title: Hepatitis C virus-induced vasculitis: therapeutic options
  publication-title: Ann. Rheum. Dis.
– volume: 6
  start-page: 178
  year: 2004
  end-page: 180
  ident: bib89
  article-title: Lymphopenia and autoimmune diseases
  publication-title: Arthritis Res. Ther.
– volume: 38
  start-page: J109
  year: 2012
  end-page: J119
  ident: bib160
  article-title: Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity
  publication-title: J. Autoimmun.
– volume: 38
  start-page: 373
  year: 2020
  end-page: 382
  ident: bib190
  article-title: COVID-19: the new challenge for rheumatologists
  publication-title: Clin. Exp. Rheumatol.
– volume: 6
  start-page: 56
  year: 2018
  ident: bib127
  article-title: Cytokine release syndrome
  publication-title: J. Immunother. Canc.
– year: 2020
  ident: bib167
  article-title: Reinfection could not occur in SARS-CoV-2 infected rhesus macaques
  publication-title: BioRxiv
– volume: 9
  start-page: 761
  year: 2020
  end-page: 770
  ident: bib105
  article-title: Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients, Emerg
  publication-title: Microb. Infect.
– year: 2020
  ident: bib75
  article-title: Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent
  publication-title: J. Clin. Invest.
– year: 2020
  ident: bib85
  article-title: Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions
  publication-title: BioRxiv
– volume: 5
  start-page: 562
  year: 2020
  end-page: 569
  ident: bib62
  article-title: Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
  publication-title: Nat. Microbiol.
– volume: 79
  start-page: 668
  year: 2020
  end-page: 669
  ident: bib136
  article-title: COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD
  publication-title: Ann. Rheum. Dis.
– volume: 369
  start-page: m2123
  year: 2020
  ident: bib186
  article-title: Pediatric inflammatory syndrome temporally related to covid-19
  publication-title: BMJ
– year: 2020
  ident: bib126
  article-title: Clinical features of 69 cases with coronavirus disease 2019 in wuhan, China
  publication-title: Clin. Infect. Dis.
– year: 2020
  ident: bib122
  article-title: Early safety indicators of COVID-19 convalescent plasma in 5,000 patients
  publication-title: J. Clin. Invest.
– volume: 11
  start-page: 995
  year: 2020
  end-page: 998
  ident: bib188
  article-title: Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host–virus interaction, and proposed neurotropic mechanisms
  publication-title: ACS Chem. Neurosci.
– volume: 153
  start-page: 109
  year: 2010
  end-page: 120
  ident: bib144
  article-title: Macrophage activation syndrome in autoimmune disease
  publication-title: Int. Arch. Allergy Immunol.
– volume: 46
  start-page: 846
  year: 2020
  end-page: 848
  ident: bib3
  article-title: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
  publication-title: Intensive Care Med.
– volume: 114
  start-page: 734
  year: 2017
  end-page: 739
  ident: bib15
  article-title: Cocapture of cognate and bystander antigens can activate autoreactive B cells
  publication-title: Proc. Natl. Acad. Sci. Unit. States Am.
– volume: 383
  start-page: 1503
  year: 2014
  end-page: 1516
  ident: bib143
  article-title: Adult haemophagocytic syndrome
  publication-title: Lancet
– volume: 28
  start-page: 277
  year: 2014
  end-page: 292
  ident: bib141
  article-title: Macrophage activation syndrome and cytokine-directed therapies
  publication-title: Best Pract. Res. Clin. Rheumatol.
– year: 2020
  ident: bib47
  article-title: Tocilizumab treatment in COVID-19: a single center experience
  publication-title: J. Med. Virol.
– year: 2020
  ident: bib135
  article-title: Anti-inflammatory therapy may ameliorate the clinical picture of COVID-19
  publication-title: Ann. Rheum. Dis.
– year: 2020
  ident: bib69
  article-title: Clinical Characteristics of 140 Patients Infected with SARS‐CoV‐2 in Wuhan
– volume: 84
  start-page: 81
  year: 2005
  end-page: 89
  ident: bib14
  article-title: Sjögren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases
  publication-title: Medicine (Baltim.)
– year: 2020
  ident: bib138
  article-title: COVID-19 in rheumatic disease patients on immunosuppressive agents
  publication-title: Semin. Arthritis Rheum.
– volume: 15
  start-page: 1170
  year: 2009
  end-page: 1178
  ident: bib54
  article-title: Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
  publication-title: Nat. Med.
– year: 2020
  ident: bib97
  article-title: Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors
  publication-title: MedRxiv
– volume: 217
  start-page: 108480
  year: 2020
  ident: bib177
  article-title: Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases
  publication-title: Clin. Immunol.
– volume: 34
  start-page: 691
  year: 2015
  end-page: 698
  ident: bib16
  article-title: Correlation between systemic lupus erythematosus and cytomegalovirus infection detected by different methods
  publication-title: Clin. Rheumatol.
– volume: 9
  year: 2020
  ident: bib88
  article-title: Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome
  publication-title: Elife
– volume: 395
  start-page: 1607
  year: 2020
  end-page: 1608
  ident: bib38
  article-title: Hyperinflammatory shock in children during COVID-19 pandemic
  publication-title: Lancet
– volume: 255
  start-page: 5
  year: 2013
  end-page: 12
  ident: bib142
  article-title: Immunity to viruses
  publication-title: Immunol. Rev.
– volume: 8
  start-page: 959
  year: 2016
  end-page: 970
  ident: bib129
  article-title: Immunotherapeutic implications of IL-6 blockade for cytokine storm
  publication-title: Immunotherapy
– year: 2020
  ident: bib30
  article-title: Autoimmune hemolytic anemia associated with Covid‐19 infection
  publication-title: Br. J. Haematol.
– volume: 27
  start-page: 992
  year: 2020
  end-page: 1000.e3
  ident: bib133
  article-title: Complex immune dysregulation in COVID-19 patients with severe respiratory failure
  publication-title: Cell Host Microbe
– volume: 17
  start-page: 935
  year: 2018
  end-page: 941
  ident: bib52
  article-title: Nature versus nurture in the spectrum of rheumatic diseases: classification of spondyloarthritis as autoimmune or autoinflammatory
  publication-title: Autoimmun. Rev.
– volume: 27
  start-page: 883
  year: 2020
  end-page: 890
  ident: bib73
  article-title: Heightened innate immune responses in the respiratory tract of COVID-19 patients
  publication-title: Cell Host Microbe
– start-page: 104389
  year: 2020
  ident: bib61
  article-title: Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: a computational biology approach
  publication-title: Infect. Genet. Evol.
– year: 2020
  ident: bib59
  article-title: Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease-2019 (COVID-19)
  publication-title: HLA
– volume: 201
  start-page: 1372
  year: 2020
  end-page: 1379
  ident: bib68
  article-title: Clinical features of 85 fatal cases of COVID-19 from wuhan: a retrospective observational study
  publication-title: Am. J. Respir. Crit. Care Med.
– volume: 221
  start-page: 1762
  year: 2020
  end-page: 1769
  ident: bib102
  article-title: Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia
  publication-title: J. Infect. Dis.
– volume: 39
  start-page: 2088
  year: 2009
  end-page: 2094
  ident: bib90
  article-title: Homeostatic proliferation and survival of naïve and memory T cells
  publication-title: Eur. J. Immunol.
– volume: 39
  start-page: 529
  year: 2017
  end-page: 539
  ident: bib86
  article-title: Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
  publication-title: Semin. Immunopathol.
– volume: 15
  start-page: 547
  year: 2018
  end-page: 562
  ident: bib187
  article-title: Guillain–Barré syndrome, transverse myelitis and infectious diseases
  publication-title: Cell. Mol. Immunol.
– volume: 395
  start-page: 1033
  year: 2020
  end-page: 1034
  ident: bib132
  article-title: COVID-19: consider cytokine storm syndromes and immunosuppression
  publication-title: Lancet
– year: 2020
  ident: bib45
  article-title: Lupus anticoagulant and abnormal coagulation tests in patients with covid-19
  publication-title: N. Engl. J. Med.
– year: 2020
  ident: bib24
  article-title: Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2
  publication-title: J. Clin. Neurosci.
– volume: 395
  start-page: 1481
  year: 2020
  ident: bib36
  article-title: Atypical presentation of COVID-19 in young infants
  publication-title: Lancet
– volume: 117
  start-page: 10970
  year: 2020
  end-page: 10975
  ident: bib130
  article-title: Effective treatment of severe COVID-19 patients with tocilizumab
  publication-title: Proc. Natl. Acad. Sci. Unit. States Am.
– year: 2020
  ident: bib113
  article-title: Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France
  publication-title: MedRxiv
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib113
  article-title: Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France
  publication-title: MedRxiv
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib78
  article-title: An inflammatory cytokine signature helps predict COVID-19 severity and death
  publication-title: MedRxiv
– volume: 41
  start-page: 1351
  issue: 6
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib27
  article-title: Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital
  publication-title: Neurol. Sci.
  doi: 10.1007/s10072-020-04449-8
– volume: 13
  start-page: 1562
  year: 2007
  ident: 10.1016/j.jaut.2020.102506_bib170
  article-title: Duration of antibody responses after severe acute respiratory syndrome
  publication-title: Emerg. Infect. Dis.
  doi: 10.3201/eid1310.070576
– volume: 7
  start-page: e741
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib19
  article-title: Guillain-Barré syndrome related to COVID-19 infection
  publication-title: Neurol. Neuroimmunol. Neuroinflammation.
  doi: 10.1212/NXI.0000000000000741
– volume: 15
  start-page: 547
  year: 2018
  ident: 10.1016/j.jaut.2020.102506_bib187
  article-title: Guillain–Barré syndrome, transverse myelitis and infectious diseases
  publication-title: Cell. Mol. Immunol.
  doi: 10.1038/cmi.2017.142
– volume: 16
  start-page: 47
  year: 2015
  ident: 10.1016/j.jaut.2020.102506_bib194
  article-title: Genetics and vaccines in the era of personalized medicine
  publication-title: Curr. Genom.
  doi: 10.2174/1389202916666141223220551
– volume: 395
  start-page: 1339
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib173
  article-title: SARS-CoV-2 shedding and infectivity
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30868-0
– year: 2010
  ident: 10.1016/j.jaut.2020.102506_bib149
  article-title: Tocilizumab for rheumatoid arthritis
– volume: 7
  year: 2014
  ident: 10.1016/j.jaut.2020.102506_bib181
  article-title: Clinical and epidemiological characteristics of Kawasaki disease
  publication-title: Jundishapur J. Microbiol.
  doi: 10.5812/jjm.11014
– volume: 27
  start-page: 992
  issue: 10
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib133
  article-title: Complex immune dysregulation in COVID-19 patients with severe respiratory failure
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2020.04.009
– volume: 9
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib88
  article-title: Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome
  publication-title: Elife
  doi: 10.7554/eLife.57555
– volume: 19
  start-page: 102554
  issue: 7
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib121
  article-title: Convalescent plasma in Covid-19: possible mechanisms of action
  publication-title: Autoimmun. Rev.
  doi: 10.1016/j.autrev.2020.102554
– volume: 46
  start-page: 1089
  issue: 6
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib46
  article-title: High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
  publication-title: Intensive Care Med.
  doi: 10.1007/s00134-020-06062-x
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib49
  article-title: Baricitinib therapy in COVID-19: a pilot study on safety and clinical impact
  publication-title: J. Infect.
  doi: 10.1016/j.jinf.2020.04.017
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib85
  article-title: Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions
  publication-title: BioRxiv
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib23
  article-title: Guillain‐Barre syndrome during SARS‐CoV ‐2 pandemic: a case report and review of recent literature
  publication-title: J. Peripher. Nerv. Syst.
  doi: 10.1111/jns.12382
– volume: 27
  start-page: 883
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib73
  article-title: Heightened innate immune responses in the respiratory tract of COVID-19 patients
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2020.04.017
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib120
  article-title: Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools
  publication-title: Virol. Sin.
  doi: 10.1007/s12250-020-00207-4
– volume: 317
  start-page: 121
  issue: 80-
  year: 2007
  ident: 10.1016/j.jaut.2020.102506_bib162
  article-title: Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production
  publication-title: Science
  doi: 10.1126/science.1140485
– volume: 181
  start-page: 271
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib66
  article-title: SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor
  publication-title: Cell
  doi: 10.1016/j.cell.2020.02.052
– volume: 187
  start-page: 6143
  year: 2011
  ident: 10.1016/j.jaut.2020.102506_bib55
  article-title: Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1101284
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib122
  article-title: Early safety indicators of COVID-19 convalescent plasma in 5,000 patients
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI140200
– volume: 3
  start-page: e297
  year: 2006
  ident: 10.1016/j.jaut.2020.102506_bib50
  article-title: A proposed classification of the immunological diseases
  publication-title: PLoS Med.
  doi: 10.1371/journal.pmed.0030297
– volume: 37
  start-page: 2305
  year: 2018
  ident: 10.1016/j.jaut.2020.102506_bib53
  article-title: From autoinflammation to autoimmunity: old and recent findings
  publication-title: Clin. Rheumatol.
  doi: 10.1007/s10067-018-4209-9
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib59
  article-title: Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease-2019 (COVID-19)
  publication-title: HLA
  doi: 10.1111/tan.13941
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib83
  article-title: Disruption of the CCL5/RANTES-CCR5 pathway restores immune homeostasis and reduces plasma viral load in critical COVID-19
  publication-title: MedRxiv
– volume: 6
  start-page: 56
  year: 2018
  ident: 10.1016/j.jaut.2020.102506_bib127
  article-title: Cytokine release syndrome
  publication-title: J. Immunother. Canc.
  doi: 10.1186/s40425-018-0343-9
– volume: 26
  start-page: 477
  year: 2012
  ident: 10.1016/j.jaut.2020.102506_bib148
  article-title: Biological treatment in adult-onset Still's disease
  publication-title: Best Pract. Res. Clin. Rheumatol.
  doi: 10.1016/j.berh.2012.07.002
– volume: 11
  start-page: 762
  year: 2019
  ident: 10.1016/j.jaut.2020.102506_bib9
  article-title: Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms
  publication-title: Viruses
  doi: 10.3390/v11080762
– volume: 95
  start-page: 183
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib70
  article-title: Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression
  publication-title: Int. J. Infect. Dis.
  doi: 10.1016/j.ijid.2020.03.013
– volume: 103
  start-page: 102301
  year: 2019
  ident: 10.1016/j.jaut.2020.102506_bib11
  article-title: Bystander activation and autoimmunity
  publication-title: J. Autoimmun.
  doi: 10.1016/j.jaut.2019.06.012
– volume: 69
  start-page: 1135
  year: 2017
  ident: 10.1016/j.jaut.2020.102506_bib125
  article-title: Review: cytokine storm syndrome: looking toward the precision medicine era
  publication-title: Arthritis Rheum.
  doi: 10.1002/art.40071
– volume: 15
  start-page: R39
  year: 2013
  ident: 10.1016/j.jaut.2020.102506_bib153
  article-title: Involvement of TLR7 MyD88-dependent signaling pathway in the pathogenesis of adult-onset Still's disease
  publication-title: Arthritis Res. Ther.
  doi: 10.1186/ar4193
– volume: 176
  start-page: 7278
  year: 2006
  ident: 10.1016/j.jaut.2020.102506_bib147
  article-title: IL-1β breaks tolerance through expansion of CD25 + effector T cells
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.176.12.7278
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib118
  article-title: Analysis of a SARS-CoV-2 infected individual reveals development of potent neutralizing antibodies to distinct epitopes with limited somatic mutation
  publication-title: Immunity
  doi: 10.1016/j.immuni.2020.06.001
– volume: 55
  start-page: 102763
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib80
  article-title: Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2020.102763
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib60
  article-title: The ABO blood group locus and a chromosome 3 gene cluster associate with SARS-CoV-2 respiratory failure in an Italian-Spanish genome-wide association analysis
  publication-title: MedRxiv
– volume: 108
  start-page: 335
  year: 2001
  ident: 10.1016/j.jaut.2020.102506_bib94
  article-title: T cell homeostasis and systemic autoimmunity
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI200112173
– volume: 8
  start-page: 365
  year: 2011
  ident: 10.1016/j.jaut.2020.102506_bib158
  article-title: Sex differences in disease severity among patients with systemic lupus erythematosus
  publication-title: Gend. Med.
  doi: 10.1016/j.genm.2011.10.003
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib140
  article-title: Rates of symptomatic SARS-CoV-2 infection in patients with autoimmune liver diseases in Northern Italy: a telemedicine study
  publication-title: Clin. Gastroenterol. Hepatol.
  doi: 10.1016/j.cgh.2020.05.047
– volume: 15
  start-page: 458
  year: 2018
  ident: 10.1016/j.jaut.2020.102506_bib104
  article-title: When worlds collide: Th17 and Treg cells in cancer and autoimmunity
  publication-title: Cell. Mol. Immunol.
  doi: 10.1038/s41423-018-0004-4
– volume: 395
  start-page: 497
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib123
  article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30183-5
– volume: 8
  start-page: 152
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib165
  article-title: Gender differences in patients with COVID-19: focus on severity and mortality
  publication-title: Front. Public. Health
  doi: 10.3389/fpubh.2020.00152
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib167
  article-title: Reinfection could not occur in SARS-CoV-2 infected rhesus macaques
  publication-title: BioRxiv
– volume: 38
  start-page: 337
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib192
  article-title: COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?
  publication-title: Clin. Exp. Rheumatol.
  doi: 10.55563/clinexprheumatol/xcdary
– volume: 84
  start-page: 81
  year: 2005
  ident: 10.1016/j.jaut.2020.102506_bib14
  article-title: Sjögren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases
  publication-title: Medicine (Baltim.)
  doi: 10.1097/01.md.0000157397.30055.c9
– start-page: 1
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib131
– volume: 382
  start-page: e38
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib43
  article-title: Coagulopathy and antiphospholipid antibodies in patients with covid-19
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMc2007575
– volume: 20
  start-page: 363
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib6
  article-title: The trinity of COVID-19: immunity, inflammation and intervention
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/s41577-020-0311-8
– volume: 215
  start-page: 108426
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib176
  article-title: On the molecular determinants of the SARS-CoV-2 attack
  publication-title: Clin. Immunol.
  doi: 10.1016/j.clim.2020.108426
– volume: 10
  year: 2019
  ident: 10.1016/j.jaut.2020.102506_bib145
  article-title: The immunology of macrophage activation syndrome
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2019.00119
– volume: 395
  start-page: 1481
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib36
  article-title: Atypical presentation of COVID-19 in young infants
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30980-6
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib35
  article-title: Sudden severe thrombocytopenia in a patient in the recovery stage of COVID-19
  publication-title: Lancet Haematol.
  doi: 10.1016/S2352-3026(20)30175-7
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib41
  article-title: Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.120.048360
– volume: 117
  start-page: 10970
  issue: 20
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib130
  article-title: Effective treatment of severe COVID-19 patients with tocilizumab
  publication-title: Proc. Natl. Acad. Sci. Unit. States Am.
  doi: 10.1073/pnas.2005615117
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib2
– volume: 31
  start-page: 781
  year: 2011
  ident: 10.1016/j.jaut.2020.102506_bib151
  article-title: The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus
  publication-title: J. Interferon Cytokine Res.
  doi: 10.1089/jir.2011.0047
– volume: 14
  year: 2019
  ident: 10.1016/j.jaut.2020.102506_bib182
  article-title: Epidemiological and clinical features of Kawasaki disease in Spain over 5 years and risk factors for aneurysm development. (2011-2016): KAWA-RACE study group
  publication-title: PloS One
  doi: 10.1371/journal.pone.0215665
– volume: 13
  start-page: 708
  year: 2014
  ident: 10.1016/j.jaut.2020.102506_bib155
  article-title: Adult-onset Still's disease
  publication-title: Autoimmun. Rev.
  doi: 10.1016/j.autrev.2014.01.058
– volume: 141
  start-page: 381
  year: 2005
  ident: 10.1016/j.jaut.2020.102506_bib183
  article-title: Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease
  publication-title: Clin. Exp. Immunol.
  doi: 10.1111/j.1365-2249.2005.02821.x
– start-page: 16769
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib33
  article-title: Thrombocytopenia as an initial manifestation of COVID‐19; case series and literature review
  publication-title: Br. J. Haematol.
– year: 2013
  ident: 10.1016/j.jaut.2020.102506_bib58
– volume: 382
  start-page: 727
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib1
  article-title: A novel coronavirus from patients with pneumonia in China, 2019
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2001017
– volume: 6
  start-page: 178
  year: 2004
  ident: 10.1016/j.jaut.2020.102506_bib89
  article-title: Lymphopenia and autoimmune diseases
  publication-title: Arthritis Res. Ther.
  doi: 10.1186/ar1208
– volume: 10
  start-page: 1
  year: 2019
  ident: 10.1016/j.jaut.2020.102506_bib146
  article-title: Signaling through gp130 compromises suppressive function in human FOXP3+ regulatory T cells
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2019.01532
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib8
  article-title: Mathematical modeling of interaction between innate and adaptive immune responses in COVID‐19 and implications for viral pathogenesis
  publication-title: J. Med. Virol.
  doi: 10.1002/jmv.25866
– volume: 203
  start-page: 1021
  year: 2011
  ident: 10.1016/j.jaut.2020.102506_bib185
  article-title: Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a “new” virus associated with Kawasaki disease
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/jiq136
– start-page: 1
  year: 2013
  ident: 10.1016/j.jaut.2020.102506_bib154
  article-title: Adult onset Still's disease: a case report with a rare clinical manifestation and pathophysiological correlations
  publication-title: Case Rep. Med.
  doi: 10.1155/2013/981232
– volume: 1
  start-page: 45
  year: 2015
  ident: 10.1016/j.jaut.2020.102506_bib161
  article-title: Sex hormones and gender disparity in immunity and autoimmunity
  publication-title: Italy J. Gender-Specifi c Med.
– volume: 47
  start-page: 764
  year: 1988
  ident: 10.1016/j.jaut.2020.102506_bib18
  article-title: Adult onset Still's disease and viral infections
  publication-title: Ann. Rheum. Dis.
  doi: 10.1136/ard.47.9.764
– volume: 17
  start-page: 533
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib72
  article-title: Functional exhaustion of antiviral lymphocytes in COVID-19 patients
  publication-title: Cell. Mol. Immunol.
  doi: 10.1038/s41423-020-0402-2
– volume: 19
  start-page: 102556
  issue: 7
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib175
  article-title: Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons
  publication-title: Autoimmun. Rev.
  doi: 10.1016/j.autrev.2020.102556
– volume: 8
  start-page: 959
  year: 2016
  ident: 10.1016/j.jaut.2020.102506_bib129
  article-title: Immunotherapeutic implications of IL-6 blockade for cytokine storm
  publication-title: Immunotherapy
  doi: 10.2217/imt-2016-0020
– volume: 395
  start-page: 1607
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib38
  article-title: Hyperinflammatory shock in children during COVID-19 pandemic
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)31094-1
– volume: 815
  start-page: 334
  year: 1997
  ident: 10.1016/j.jaut.2020.102506_bib17
  article-title: Herpes viruses in multicase families with rheumatoid arthritis and systemic lupus erythematosus
  publication-title: Ann. N. Y. Acad. Sci.
  doi: 10.1111/j.1749-6632.1997.tb52078.x
– volume: 39
  start-page: 196
  year: 2017
  ident: 10.1016/j.jaut.2020.102506_bib156
  article-title: Gender Medicine: a interdisciplinary approach to medicine
  publication-title: G. Ital. Med. Lav. Ergon.
– volume: 39
  start-page: 2088
  year: 2009
  ident: 10.1016/j.jaut.2020.102506_bib90
  article-title: Homeostatic proliferation and survival of naïve and memory T cells
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.200939444
– volume: 38
  start-page: J109
  year: 2012
  ident: 10.1016/j.jaut.2020.102506_bib160
  article-title: Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity
  publication-title: J. Autoimmun.
  doi: 10.1016/j.jaut.2011.10.003
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib37
  article-title: COVID-19 and Kawasaki disease: novel virus and novel case
  publication-title: Hosp. Pediatr.
  doi: 10.1542/hpeds.2020-0123
– volume: 217
  start-page: 108480
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib177
  article-title: Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases
  publication-title: Clin. Immunol.
  doi: 10.1016/j.clim.2020.108480
– volume: 28
  start-page: 621
  year: 2019
  ident: 10.1016/j.jaut.2020.102506_bib98
  article-title: CD44v3 and CD44v6 isoforms on T cells are able to discriminate different disease activity degrees and phenotypes in systemic lupus erythematosus patients
  publication-title: Lupus
  doi: 10.1177/0961203319838063
– volume: 369
  start-page: m2123
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib186
  article-title: Pediatric inflammatory syndrome temporally related to covid-19
  publication-title: BMJ
  doi: 10.1136/bmj.m2123
– volume: 153
  start-page: 109
  year: 2010
  ident: 10.1016/j.jaut.2020.102506_bib144
  article-title: Macrophage activation syndrome in autoimmune disease
  publication-title: Int. Arch. Allergy Immunol.
  doi: 10.1159/000312628
– volume: 213
  start-page: 904
  year: 2016
  ident: 10.1016/j.jaut.2020.102506_bib107
  article-title: Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/jiv380
– volume: 5
  start-page: 33
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib92
  article-title: Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study
  publication-title: Signal Transduct. Target. Theroy
  doi: 10.1038/s41392-020-0148-4
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib22
  article-title: Guillain-Barré syndrome as a complication of SARS-CoV-2 infection
  publication-title: Brain Behav. Immun.
  doi: 10.1016/j.bbi.2020.04.074
– volume: 58
  start-page: 71
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib152
  article-title: Autoinflammatory pathogenesis and targeted therapy for adult-onset Still's disease
  publication-title: Clin. Rev. Allergy Immunol.
  doi: 10.1007/s12016-019-08747-8
– volume: 12
  start-page: 22
  year: 2012
  ident: 10.1016/j.jaut.2020.102506_bib51
  article-title: Autoinflammation and autoimmunity: bridging the divide
  publication-title: Autoimmun. Rev.
  doi: 10.1016/j.autrev.2012.07.018
– volume: 12
  start-page: 282
  year: 2012
  ident: 10.1016/j.jaut.2020.102506_bib56
  article-title: Integration of B cell responses through Toll-like receptors and antigen receptors
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri3190
– volume: 229
  start-page: 173
  year: 2009
  ident: 10.1016/j.jaut.2020.102506_bib99
  article-title: The significance of OX40 and OX40L to T-cell biology and immune disease
  publication-title: Immunol. Rev.
  doi: 10.1111/j.1600-065X.2009.00766.x
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib77
  article-title: Elevated plasma level of selective cytokines in COVID-19 patients reflect viral load and lung injury
  publication-title: Natl. Sci. Rev.
– volume: 26
  start-page: 453
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib109
  article-title: Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19
  publication-title: Nat. Med.
  doi: 10.1038/s41591-020-0819-2
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib24
  article-title: Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2
  publication-title: J. Clin. Neurosci.
  doi: 10.1016/j.jocn.2020.05.016
– volume: 323
  start-page: 2249
  issue: 22
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib5
  article-title: Interpreting diagnostic tests for SARS-CoV-2
  publication-title: J. Am. Med. Assoc.
  doi: 10.1001/jama.2020.8259
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib81
  article-title: Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China
  publication-title: MedRxiv
– volume: 131
  start-page: 1652
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib25
  article-title: Post SARS-CoV-2 guillain-barré syndrome
  publication-title: Clin. Neurophysiol.
  doi: 10.1016/j.clinph.2020.05.003
– volume: 46
  start-page: 846
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib3
  article-title: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
  publication-title: Intensive Care Med.
  doi: 10.1007/s00134-020-05991-x
– volume: 86
  start-page: 4234
  year: 2012
  ident: 10.1016/j.jaut.2020.102506_bib168
  article-title: Primary severe acute respiratory syndrome coronavirus infection limits replication but not lung inflammation upon homologous rechallenge
  publication-title: J. Virol.
  doi: 10.1128/JVI.06791-11
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib137
  article-title: Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia
  publication-title: Ann. Rheum. Dis.
  doi: 10.1136/annrheumdis-2020-217549
– volume: 30
  start-page: 121
  year: 2011
  ident: 10.1016/j.jaut.2020.102506_bib159
  article-title: Spondyloarthritis in women: differences in disease onset, clinical presentation, and Bath Ankylosing Spondylitis Disease Activity and Functional indices (BASDAI and BASFI) between men and women with spondyloarthritides
  publication-title: Clin. Rheumatol.
  doi: 10.1007/s10067-010-1581-5
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib26
  article-title: Miller Fisher Syndrome and polyneuritis cranialis in COVID-19
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000009619
– volume: 109
  start-page: 102442
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib193
  article-title: Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
  publication-title: J. Autoimmun.
  doi: 10.1016/j.jaut.2020.102442
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib71
  article-title: Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in wuhan, China
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/ciaa248
– volume: 579
  start-page: 270
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib110
  article-title: A pneumonia outbreak associated with a new coronavirus of probable bat origin
  publication-title: Nature
  doi: 10.1038/s41586-020-2012-7
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib174
  article-title: Predicting infectious SARS-CoV-2 from diagnostic samples
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/ciaa638
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib69
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib189
  article-title: Cranial neuropathies and COVID-19: neurotropism and autoimmunity
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000009921
– volume: 180
  start-page: 7112
  year: 2008
  ident: 10.1016/j.jaut.2020.102506_bib150
  article-title: Cutting edge: foxp3 + CD4 + CD25 + regulatory T cells induced by IL-2 and TGF-β are resistant to Th17 conversion by IL-6
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.180.11.7112
– volume: 5
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib67
  article-title: TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes
  publication-title: Sci. Immunol.
  doi: 10.1126/sciimmunol.abc3582
– volume: 109
  start-page: 4882
  year: 2007
  ident: 10.1016/j.jaut.2020.102506_bib100
  article-title: CD137 stimulation delivers an antigen-independent growth signal for T lymphocytes with memory phenotype
  publication-title: Blood
  doi: 10.1182/blood-2006-10-043463
– start-page: 1
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib111
  article-title: Antibody detection and dynamic characteristics in patients with COVID-19
  publication-title: Clin. Infect. Dis.
– volume: 79
  start-page: 668
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib136
  article-title: COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD
  publication-title: Ann. Rheum. Dis.
  doi: 10.1136/annrheumdis-2020-217442
– volume: 11
  start-page: 1
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib79
  article-title: Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2020.00827
– volume: 26
  start-page: 681
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib65
  article-title: SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
  publication-title: Nat. Med.
  doi: 10.1038/s41591-020-0868-6
– volume: 28
  start-page: 277
  year: 2014
  ident: 10.1016/j.jaut.2020.102506_bib141
  article-title: Macrophage activation syndrome and cytokine-directed therapies
  publication-title: Best Pract. Res. Clin. Rheumatol.
  doi: 10.1016/j.berh.2014.03.002
– volume: 57
  start-page: 2863
  year: 2008
  ident: 10.1016/j.jaut.2020.102506_bib12
  article-title: Viral trigger for type 1 diabetes: pros and cons
  publication-title: Diabetes
  doi: 10.2337/db07-1023
– volume: 5
  start-page: 562
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib62
  article-title: Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
  publication-title: Nat. Microbiol.
  doi: 10.1038/s41564-020-0688-y
– volume: 383
  start-page: 1503
  year: 2014
  ident: 10.1016/j.jaut.2020.102506_bib143
  article-title: Adult haemophagocytic syndrome
  publication-title: Lancet
  doi: 10.1016/S0140-6736(13)61048-X
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib134
  article-title: Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept
  publication-title: Ann. Rheum. Dis.
  doi: 10.1136/annrheumdis-2020-217362
– volume: 130
  start-page: 2757
  issue: 6
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib117
  article-title: Deployment of convalescent plasma for the prevention and treatment of COVID-19
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI138745
– volume: 9
  start-page: 45
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib63
  article-title: Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues
  publication-title: Infect. Disease Poverty.
  doi: 10.1186/s40249-020-00662-x
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib172
– volume: 181
  start-page: 1036
  issue: 5
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib76
  article-title: Imbalanced host response to SARS-CoV-2 drives development of COVID-19
  publication-title: Cell
  doi: 10.1016/j.cell.2020.04.026
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib106
  article-title: Mortality of COVID-19 is associated with cellular immune function compared to immune function in Chinese han population
  publication-title: MedRxiv
– volume: 17
  start-page: 1
  year: 2002
  ident: 10.1016/j.jaut.2020.102506_bib103
  article-title: Autoreactive CD8 T cells in organ-specific autoimmunity
  publication-title: Immunity
  doi: 10.1016/S1074-7613(02)00338-2
– volume: 382
  start-page: e43
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib29
  article-title: Immune thrombocytopenic purpura in a patient with covid-19
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMc2010472
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib64
  article-title: Multiorgan and renal tropism of SARS-CoV-2
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMc2011400
– volume: 255
  start-page: 5
  year: 2013
  ident: 10.1016/j.jaut.2020.102506_bib142
  article-title: Immunity to viruses
  publication-title: Immunol. Rev.
  doi: 10.1111/imr.12109
– volume: 92
  start-page: 512
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib171
  article-title: Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus‐associated illnesses
  publication-title: J. Med. Virol.
  doi: 10.1002/jmv.25715
– volume: 95
  start-page: 100
  year: 2018
  ident: 10.1016/j.jaut.2020.102506_bib10
  article-title: Molecular mimicry and autoimmunity
  publication-title: J. Autoimmun.
  doi: 10.1016/j.jaut.2018.10.012
– volume: 369
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib42
  article-title: Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study
  publication-title: BMJ
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib47
  article-title: Tocilizumab treatment in COVID-19: a single center experience
  publication-title: J. Med. Virol.
  doi: 10.1002/jmv.25801
– volume: 4
  year: 2019
  ident: 10.1016/j.jaut.2020.102506_bib119
  article-title: Anti–spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection
  publication-title: JCI Insight
  doi: 10.1172/jci.insight.123158
– volume: 181
  start-page: 1304
  year: 2019
  ident: 10.1016/j.jaut.2020.102506_bib57
  article-title: Respiratory virus infection triggers acute psoriasis flares across different clinical subtypes and genetic backgrounds
  publication-title: Br. J. Dermatol.
  doi: 10.1111/bjd.18203
– volume: 8
  start-page: 420
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib101
  article-title: Pathological findings of COVID-19 associated with acute respiratory distress syndrome
  publication-title: Lancet Respir. Med.
  doi: 10.1016/S2213-2600(20)30076-X
– volume: 39
  start-page: 529
  year: 2017
  ident: 10.1016/j.jaut.2020.102506_bib86
  article-title: Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
  publication-title: Semin. Immunopathol.
  doi: 10.1007/s00281-017-0629-x
– start-page: 197
  year: 2019
  ident: 10.1016/j.jaut.2020.102506_bib128
  article-title: Cytokines in cytokine storm syndrome
– volume: 4
  start-page: e79
  year: 2018
  ident: 10.1016/j.jaut.2020.102506_bib157
  article-title: Gender differences in rheumatology and the point of view of the Italian Society for Rheumatology (SIR)
  publication-title: Italy J. Gender-Specific Med.
– volume: 395
  start-page: 1771
  issue: 10239
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib39
  article-title: An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)31103-X
– volume: 30
  start-page: 313
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib48
  article-title: Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19)
  publication-title: J. Microbiol. Biotechnol.
  doi: 10.4014/jmb.2003.03011
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib75
  article-title: Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI138554
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib7
  article-title: Antibody responses to SARS-CoV-2 in patients with COVID-19
  publication-title: Nat. Med.
  doi: 10.1038/s41591-020-0897-1
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib20
  article-title: Guillain–barré syndrome associated with SARS-CoV-2
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMc2009191
– volume: 201
  start-page: 1372
  issue: 11
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib68
  article-title: Clinical features of 85 fatal cases of COVID-19 from wuhan: a retrospective observational study
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/rccm.202003-0543OC
– volume: 57
  start-page: 12
  year: 2013
  ident: 10.1016/j.jaut.2020.102506_bib96
  article-title: Autoimmune effector memory T cells: the bad and the good
  publication-title: Immunol. Res.
  doi: 10.1007/s12026-013-8448-1
– volume: 395
  start-page: 1033
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib132
  article-title: COVID-19: consider cytokine storm syndromes and immunosuppression
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30628-0
– start-page: 1
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib87
  article-title: COVID-19: the vasculature unleashed
  publication-title: Nat. Rev. Immunol.
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib180
  article-title: Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases
  publication-title: Br. J. Dermatol.
  doi: 10.1111/bjd.19163
– volume: 43
  start-page: 317
  year: 2010
  ident: 10.1016/j.jaut.2020.102506_bib184
  article-title: Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease
  publication-title: Autoimmunity
  doi: 10.3109/08916930903405891
– start-page: 104389
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib61
  article-title: Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: a computational biology approach
  publication-title: Infect. Genet. Evol.
  doi: 10.1016/j.meegid.2020.104389
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib40
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib74
  article-title: Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients
  publication-title: Natl. Sci. Rev.
– volume: 221
  start-page: 1762
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib102
  article-title: Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/jiaa150
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib34
  article-title: COVID-19-associated immune thrombocytopenia
  publication-title: Br. J. Haematol.
  doi: 10.1111/bjh.16850
– start-page: 26138
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib32
  article-title: COVID‐19 presenting with immune thrombocytopenia: a case report and review of the literature
  publication-title: J. Med. Virol.
  doi: 10.1002/jmv.26138
– volume: 19
  start-page: 102572
  issue: 7
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib179
  article-title: Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms
  publication-title: Autoimmun. Rev.
  doi: 10.1016/j.autrev.2020.102572
– volume: 93
  start-page: 297
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib169
  article-title: Recurrence of positive SARS-CoV-2 RNA in COVID-19: a case report
  publication-title: Int. J. Infect. Dis.
  doi: 10.1016/j.ijid.2020.03.003
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib28
  article-title: COVID-19 presenting with ophthalmoparesis from cranial nerve palsy
  publication-title: Neurology
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib82
  article-title: Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome
  publication-title: MedRxiv
– volume: 17
  start-page: 935
  year: 2018
  ident: 10.1016/j.jaut.2020.102506_bib52
  article-title: Nature versus nurture in the spectrum of rheumatic diseases: classification of spondyloarthritis as autoimmune or autoinflammatory
  publication-title: Autoimmun. Rev.
  doi: 10.1016/j.autrev.2018.04.002
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib97
  article-title: Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors
  publication-title: MedRxiv
– volume: 6
  start-page: 49
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib164
  article-title: Gender differences in COVID-19: some open questions
  publication-title: Italy. J. Gender-Specific Med.
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib138
  article-title: COVID-19 in rheumatic disease patients on immunosuppressive agents
  publication-title: Semin. Arthritis Rheum.
  doi: 10.1016/j.semarthrit.2020.05.010
– volume: 15
  start-page: 1170
  year: 2009
  ident: 10.1016/j.jaut.2020.102506_bib54
  article-title: Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
  publication-title: Nat. Med.
  doi: 10.1038/nm.2028
– volume: 114
  start-page: 734
  year: 2017
  ident: 10.1016/j.jaut.2020.102506_bib15
  article-title: Cocapture of cognate and bystander antigens can activate autoreactive B cells
  publication-title: Proc. Natl. Acad. Sci. Unit. States Am.
  doi: 10.1073/pnas.1614472114
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib135
  article-title: Anti-inflammatory therapy may ameliorate the clinical picture of COVID-19
  publication-title: Ann. Rheum. Dis.
  doi: 10.1136/annrheumdis-2020-217562
– volume: 106
  start-page: 879
  year: 2005
  ident: 10.1016/j.jaut.2020.102506_bib91
  article-title: IL-6 blocks a discrete early step in lymphopoiesis
  publication-title: Blood
  doi: 10.1182/blood-2005-02-0456
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib115
  article-title: Rapid generation of neutralizing antibody responses in COVID-19 patients
  publication-title: Cell Rep. Med.
  doi: 10.1016/j.xcrm.2020.100040
– volume: 9
  start-page: 761
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib105
  article-title: Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients, Emerg
  publication-title: Microb. Infect.
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib30
  article-title: Autoimmune hemolytic anemia associated with Covid‐19 infection
  publication-title: Br. J. Haematol.
  doi: 10.1111/bjh.16794
– volume: 11
  start-page: 995
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib188
  article-title: Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host–virus interaction, and proposed neurotropic mechanisms
  publication-title: ACS Chem. Neurosci.
  doi: 10.1021/acschemneuro.0c00122
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib4
  article-title: Neutrophil extracellular traps (NETs) as markers of disease severity in COVID-19
  publication-title: MedRxiv
– volume: 5
  start-page: 305
  year: 2013
  ident: 10.1016/j.jaut.2020.102506_bib178
  article-title: Catastrophic antiphospholipid syndrome: how to diagnose a rare but highly fatal disease
  publication-title: Ther. Adv. Musculoskelet. Disease
  doi: 10.1177/1759720X13502919
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib126
  article-title: Clinical features of 69 cases with coronavirus disease 2019 in wuhan, China
  publication-title: Clin. Infect. Dis.
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib45
  article-title: Lupus anticoagulant and abnormal coagulation tests in patients with covid-19
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMc2013656
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib112
  article-title: Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China
  publication-title: Nat. Med.
– start-page: 2
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib108
  article-title: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion
  publication-title: Cell. Mol. Immunol.
– volume: 177
  start-page: 104762
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib191
  article-title: Of chloroquine and COVID-19
  publication-title: Antivir. Res.
  doi: 10.1016/j.antiviral.2020.104762
– volume: 19
  start-page: 102575
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib139
  article-title: SARS-CoV-2 infection among patients with systemic autoimmune diseases
  publication-title: Autoimmun. Rev.
  doi: 10.1016/j.autrev.2020.102575
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib44
  article-title: Lupus anticoagulant is frequent in patients with Covid‐19
  publication-title: J. Thromb. Haemostasis
– volume: 154
  start-page: 574
  year: 2018
  ident: 10.1016/j.jaut.2020.102506_bib95
  article-title: The roles of resident, central and effector memory CD4 T-cells in protective immunity following infection or vaccination
  publication-title: Immunology
  doi: 10.1111/imm.12929
– volume: 15
  start-page: 206
  year: 2018
  ident: 10.1016/j.jaut.2020.102506_bib163
  article-title: The novel estrogenic receptor GPR30 alleviates ischemic injury by inhibiting TLR4-mediated microglial inflammation
  publication-title: J. Neuroinflammation
  doi: 10.1186/s12974-018-1246-x
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib114
  article-title: Towards the next phase: evaluation of serological assays for diagnostics and exposure assessment
  publication-title: MedRxiv
– volume: 7
  year: 2012
  ident: 10.1016/j.jaut.2020.102506_bib166
  article-title: Lack of innate Interferon responses during SARS coronavirus infection in a vaccination and reinfection ferret model
  publication-title: PloS One
  doi: 10.1371/journal.pone.0045842
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib31
  article-title: Simultaneous onset of COVID‐19 and autoimmune haemolytic anaemia
  publication-title: Br. J. Haematol.
  doi: 10.1111/bjh.16786
– volume: 53
  start-page: 368
  issue: 3
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib124
  article-title: TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor Fedratinib
  publication-title: J. Microbiol. Immunol. Infect.
  doi: 10.1016/j.jmii.2020.03.005
– volume: 98
  start-page: 23
  year: 2005
  ident: 10.1016/j.jaut.2020.102506_bib93
  article-title: A causal link between lymphopenia and autoimmunity
  publication-title: Immunol. Lett.
  doi: 10.1016/j.imlet.2004.10.022
– ident: 10.1016/j.jaut.2020.102506_bib84
– volume: 20
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib21
  article-title: Guillain-Barré Syndrome associated with SARS-CoV-2 infection
  publication-title: IDCases
  doi: 10.1016/j.idcr.2020.e00771
– volume: 38
  start-page: 373
  issue: 3
  year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib190
  article-title: COVID-19: the new challenge for rheumatologists
  publication-title: Clin. Exp. Rheumatol.
– volume: 73
  start-page: 24
  year: 2014
  ident: 10.1016/j.jaut.2020.102506_bib13
  article-title: Hepatitis C virus-induced vasculitis: therapeutic options
  publication-title: Ann. Rheum. Dis.
  doi: 10.1136/annrheumdis-2013-203883
– year: 2020
  ident: 10.1016/j.jaut.2020.102506_bib116
  article-title: Convergent antibody responses to SARS-CoV-2 infection in convalescent individuals
  publication-title: BioRxiv
– volume: 34
  start-page: 691
  year: 2015
  ident: 10.1016/j.jaut.2020.102506_bib16
  article-title: Correlation between systemic lupus erythematosus and cytomegalovirus infection detected by different methods
  publication-title: Clin. Rheumatol.
  doi: 10.1007/s10067-015-2868-3
SSID ssj0011555
Score 2.6599784
SecondaryResourceType review_article
Snippet Coronavirus disease 2019 (COVID-19) has been categorized as evolving in overlapping phases. First, there is a viral phase that may well be asymptomatic or mild...
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 102506
SubjectTerms Adaptive Immunity - genetics
Antiphospholipid syndrome
Autoimmune Diseases - diagnosis
Autoimmune Diseases - immunology
Autoimmune Diseases - therapy
Autoimmune Diseases - virology
Autoimmunity
Betacoronavirus - immunology
Betacoronavirus - isolation & purification
Clinical Laboratory Techniques
Coronavirus Infections - diagnosis
Coronavirus Infections - epidemiology
Coronavirus Infections - immunology
Coronavirus Infections - therapy
COVID-19
COVID-19 Testing
Critical Illness
Cytokine Release Syndrome - diagnosis
Cytokine Release Syndrome - immunology
Cytokine Release Syndrome - therapy
Cytokine Release Syndrome - virology
Cytokine storm syndrome
Cytopenia
Female
Genetic Predisposition to Disease
Guillain-Barré syndrome
Humans
Immunity, Innate - genetics
Immunization, Passive - methods
Inflammation Mediators - blood
Inflammation Mediators - immunology
Kawasaki disease
Macrophage Activation - genetics
Macrophage Activation - immunology
Male
Pandemics
Pneumonia, Viral - diagnosis
Pneumonia, Viral - epidemiology
Pneumonia, Viral - immunology
Pneumonia, Viral - therapy
Risk Factors
SARS-CoV-2
Severity of Illness Index
Sex Factors
Vaccines
Title Autoinflammatory and autoimmune conditions at the crossroad of COVID-19
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0896841120301281
https://dx.doi.org/10.1016/j.jaut.2020.102506
https://www.ncbi.nlm.nih.gov/pubmed/32563547
https://www.proquest.com/docview/2415836476
https://pubmed.ncbi.nlm.nih.gov/PMC7296326
Volume 114
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9RADLaqoiIuFZRHt0A1SNxQ2E3ibCbH1ULZgloOUNTbaF5Rt2qTqs0eeuG3Y2eSiAVUpB4zsaWJ7XE-a_wAeJtYianMfeStLyM0lo4UJpqcoS3JZkzhYq5GPjqeLk7w82l2ugHzvhaG0yo73x98euutu5VxJ83x1XI5_jaRxVQi4QVG9Ulbfo2Ys5W__zmkeRDgaSefMnHE1F3hTMjxOucsEQr_2w4GGU89-vfP6W_w-WcO5W8_pYPHsN2hSTELG34CG77aga0wX_J2Bx4edTfnT-HTbNXUZE1kAJftxbrQlROaF7lCxAuKi11I3xK6EQQLRdhjrZ2oSzH_-uPwQxQXz-Dk4OP3-SLqhihENsuTJirRxJY-LSfoIk1mJqhTpChG5lLbJHakEulTLAxyaz0n0WSJcc4WUywsKSF9DptVXfldENw53plCJh41lhRYxilOtDeGdJqhdyOIe-kp23UY50EXF6pPJTtXLHHFEldB4iN4N_Bchf4ad1KnvVJUXzlKvk6R-7-TKxu41mzrv3xver0rOnR8k6IrX69uFMMeyZ33ieZFsINh9ymByDTDfAT5moUMBNzQe_1NtTxrG3tToDMlOL13z_2-hEf8FColX8Fmc73yrwkyNWa_PRP78GB2-GVx_As9vhSA
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDCaKFN16GdbulT01oLfBSGzLsXwMsnVJ26SHtkNvgl5GU2x20TmH_fuRkWw03dABu1oiIJMU9QkiPwIcJEbwVOQucsaVEdcGtxRPFAZDU6LP6MLGVI08X4ymF_zoMrvcgklbC0NplSH2-5i-jtbhyyBoc3CzXA7OhqIYCY54gVB9QuXX28ROlfVgezw7ni66xwQ8MteZjDg_IoFQO-PTvK4pUSRB0EQkBhk1Pvr7-fQn_ryfRnnnXDp8Ck8CoGRjv-Y92HLVPuz4FpO_9uHRPDyeP4Ov41VTo0OhD_xYv60zVVmm6CMViTiGV2PrM7iYahgiQ-bXWCvL6pJNTr_NPkdx8RwuDr-cT6ZR6KMQmSxPmqjkOjb4azmiF6EzPeQq5XiREblQJoktWkW4lBeaE7ueFVxnibbWFCNeGLRD-gJ6VV25V8CIPN7qQiSOK17i3TJO-VA5rdGsGXe2D3GrPWkCyTj1uvgu22yya0kal6Rx6TXeh0-dzI2n2HhwdtoaRbbFoxjuJJ4AD0plndSGe_1T7mNrd4n7jh5TVOXq1U9JyEcQ-T7Oeen9oFt9ijgyRVfsQ77hId0E4vTeHKmWV2tub7zrjBBRv_7P9X6Ax9Pz-Yk8mS2O38AujfjCybfQa25X7h0iqEa_DzvkN6zZFzE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Autoinflammatory+and+autoimmune+conditions+at+the+crossroad+of+COVID-19&rft.jtitle=Journal+of+autoimmunity&rft.au=Rodr%C3%ADguez%2C+Yhojan&rft.au=Novelli%2C+Lucia&rft.au=Rojas%2C+Manuel&rft.au=De+Santis%2C+Maria&rft.date=2020-11-01&rft.eissn=1095-9157&rft.volume=114&rft.spage=102506&rft_id=info:doi/10.1016%2Fj.jaut.2020.102506&rft_id=info%3Apmid%2F32563547&rft.externalDocID=32563547
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0896-8411&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0896-8411&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0896-8411&client=summon